| GO:0048485 | Sympathetic nervous system development | 4/86 | 21/18866 | 2.27016E-06 | 0.002377266 | 0.001927173 | GATA3/SOX4/SEMA3A/TP63 | 4 |
| GO:0003283 | Atrial septum development | 4/86 | 23/18866 | 3.3355E-06 | 0.002377266 | 0.001927173 | TGFB2/SOX4/ANK2/BMPR2 | 4 |
| GO:0003179 | Heart valve morphogenesis | 5/86 | 52/18866 | 3.8427E-06 | 0.002377266 | 0.001927173 | GATA3/SMAD6/TGFB2/SOX4/BMPR2 | 5 |
| GO:0003181 | Atrioventricular valve morphogenesis | 4/86 | 24/18866 | 3.9887E-06 | 0.002377266 | 0.001927173 | SMAD6/TGFB2/SOX4/BMPR2 | 4 |
| GO:0003171 | Atrioventricular valve development | 4/86 | 26/18866 | 5.57292E-06 | 0.002481207 | 0.002011434 | SMAD6/TGFB2/SOX4/BMPR2 | 4 |
| GO:0031069 | Hair follicle morphogenesis | 4/86 | 28/18866 | 7.57961E-06 | 0.002481207 | 0.002011434 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:0003170 | Heart valve development | 5/86 | 61/18866 | 8.51768E-06 | 0.002481207 | 0.002011434 | GATA3/SMAD6/TGFB2/SOX4/BMPR2 | 5 |
| GO:0003183 | Mitral valve morphogenesis | 3/86 | 10/18866 | 1.07242E-05 | 0.002481207 | 0.002011434 | SMAD6/SOX4/BMPR2 | 3 |
| GO:0071772 | Response to BMP | 7/86 | 168/18866 | 1.16587E-05 | 0.002481207 | 0.002011434 | SORL1/FST/GATA3/SKIL/SMAD6/TGFB2/BMPR2 | 7 |
| GO:0071773 | Cellular response to BMP stimulus | 7/86 | 168/18866 | 1.16587E-05 | 0.002481207 | 0.002011434 | SORL1/FST/GATA3/SKIL/SMAD6/TGFB2/BMPR2 | 7 |
| GO:0048880 | Sensory system development | 10/86 | 394/18866 | 1.2143E-05 | 0.002481207 | 0.002011434 | SLC7A11/COL8A1/GATA3/CLIC4/SKIL/TGFB2/BDNF/SEMA3A/SLITRK6/BMPR2 | 10 |
| GO:0048730 | Epidermis morphogenesis | 4/86 | 32/18866 | 1.31282E-05 | 0.002481207 | 0.002011434 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:0003279 | Cardiac septum development | 6/86 | 114/18866 | 1.35301E-05 | 0.002481207 | 0.002011434 | GATA3/SMAD6/TGFB2/SOX4/ANK2/BMPR2 | 6 |
| GO:0003174 | Mitral valve development | 3/86 | 11/18866 | 1.46971E-05 | 0.002502712 | 0.002028868 | SMAD6/SOX4/BMPR2 | 3 |
| GO:0003230 | Cardiac atrium development | 4/86 | 36/18866 | 2.12083E-05 | 0.003370699 | 0.002732516 | TGFB2/SOX4/ANK2/BMPR2 | 4 |
| GO:1905314 | Semi-lunar valve development | 4/86 | 37/18866 | 2.36965E-05 | 0.003515909 | 0.002850233 | GATA3/SMAD6/TGFB2/BMPR2 | 4 |
| GO:0003281 | Ventricular septum development | 5/86 | 76/18866 | 2.50715E-05 | 0.003515909 | 0.002850233 | GATA3/SMAD6/TGFB2/SOX4/BMPR2 | 5 |
| GO:0060413 | Atrial septum morphogenesis | 3/86 | 16/18866 | 4.9065E-05 | 0.006498385 | 0.00526803 | TGFB2/SOX4/BMPR2 | 3 |
| GO:0048483 | Autonomic nervous system development | 4/86 | 47/18866 | 6.18134E-05 | 0.007400207 | 0.005999108 | GATA3/SOX4/SEMA3A/TP63 | 4 |
| GO:0001654 | Eye development | 9/86 | 384/18866 | 6.30723E-05 | 0.007400207 | 0.005999108 | SLC7A11/COL8A1/GATA3/CLIC4/SKIL/TGFB2/BDNF/SLITRK6/BMPR2 | 9 |
| GO:0030510 | Regulation of BMP signaling pathway | 5/86 | 93/18866 | 6.63775E-05 | 0.007400207 | 0.005999108 | SORL1/FST/SKIL/SMAD6/BMPR2 | 5 |
| GO:0150063 | Visual system development | 9/86 | 388/18866 | 6.82905E-05 | 0.007400207 | 0.005999108 | SLC7A11/COL8A1/GATA3/CLIC4/SKIL/TGFB2/BDNF/SLITRK6/BMPR2 | 9 |
| GO:0030509 | BMP signaling pathway | 6/86 | 155/18866 | 7.63551E-05 | 0.007914368 | 0.006415922 | SORL1/FST/SKIL/SMAD6/TGFB2/BMPR2 | 6 |
| GO:0003215 | Cardiac right ventricle morphogenesis | 3/86 | 20/18866 | 9.85737E-05 | 0.009791656 | 0.007937778 | GATA3/TGFB2/SOX4 | 3 |
| GO:0003177 | Pulmonary valve development | 3/86 | 21/18866 | 0.000114624 | 0.010930574 | 0.008861062 | SMAD6/TGFB2/BMPR2 | 3 |
| GO:0016358 | Dendrite development | 7/86 | 247/18866 | 0.000135064 | 0.012023407 | 0.009746987 | CPEB3/PPP1R9A/BDNF/SEMA3A/PRKG1/PACSIN1/MAP2 | 7 |
| GO:0043010 | Camera-type eye development | 8/86 | 332/18866 | 0.000136171 | 0.012023407 | 0.009746987 | SLC7A11/COL8A1/GATA3/CLIC4/SKIL/TGFB2/SLITRK6/BMPR2 | 8 |
| GO:0003205 | Cardiac chamber development | 6/86 | 174/18866 | 0.000144194 | 0.012277131 | 0.009952673 | GATA3/SMAD6/TGFB2/SOX4/ANK2/BMPR2 | 6 |
| GO:0010634 | Positive regulation of epithelial cell migration | 6/86 | 176/18866 | 0.000153468 | 0.01261616 | 0.010227512 | GATA3/SASH1/TGFB2/HDAC9/BMPR2/ITGB3 | 6 |
| GO:0090092 | Regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 7/86 | 254/18866 | 0.000160478 | 0.012752643 | 0.010338155 | SORL1/FST/SKIL/SMAD6/TGFB2/INHBB/BMPR2 | 7 |
| GO:0060393 | Regulation of pathway-restricted SMAD protein phosphorylation | 4/86 | 62/18866 | 0.000183531 | 0.014114136 | 0.011441873 | SMAD6/TGFB2/INHBB/BMPR2 | 4 |
| GO:0060037 | Pharyngeal system development | 3/86 | 26/18866 | 0.000220418 | 0.015457062 | 0.012530539 | GATA3/TGFB2/BMPR2 | 3 |
| GO:0060384 | Innervation | 3/86 | 26/18866 | 0.000220418 | 0.015457062 | 0.012530539 | GABRB3/SEMA3A/SLITRK6 | 3 |
| GO:0060389 | Pathway-restricted SMAD protein phosphorylation | 4/86 | 65/18866 | 0.000220445 | 0.015457062 | 0.012530539 | SMAD6/TGFB2/INHBB/BMPR2 | 4 |
| GO:0003148 | Outflow tract septum morphogenesis | 3/86 | 27/18866 | 0.000247155 | 0.016834784 | 0.013647414 | SMAD6/TGFB2/BMPR2 | 3 |
| GO:0031032 | Actomyosin structure organization | 6/86 | 200/18866 | 0.000306151 | 0.020274023 | 0.016435493 | PPP1R9A/NEBL/CGNL1/PGM5/ARHGAP28/MYO18A | 6 |
| GO:0003206 | Cardiac chamber morphogenesis | 5/86 | 131/18866 | 0.000331986 | 0.020492366 | 0.016612497 | GATA3/SMAD6/TGFB2/SOX4/BMPR2 | 5 |
| GO:0003231 | Cardiac ventricle development | 5/86 | 131/18866 | 0.000331986 | 0.020492366 | 0.016612497 | GATA3/SMAD6/TGFB2/SOX4/BMPR2 | 5 |
| GO:0003209 | Cardiac atrium morphogenesis | 3/86 | 30/18866 | 0.00033969 | 0.020492366 | 0.016612497 | TGFB2/SOX4/BMPR2 | 3 |
| GO:0010595 | Positive regulation of endothelial cell migration | 5/86 | 132/18866 | 0.000343832 | 0.020492366 | 0.016612497 | GATA3/SASH1/HDAC9/BMPR2/ITGB3 | 5 |
| GO:0032535 | Regulation of cellular component size | 8/86 | 383/18866 | 0.000358164 | 0.020825902 | 0.016882884 | PPP1R9A/BDNF/SEMA3A/ATP7A/ARHGAP28/BMPR2/JMY/MAP2 | 8 |
| GO:0051497 | Negative regulation of stress fiber assembly | 3/86 | 31/18866 | 0.00037485 | 0.021277191 | 0.017248729 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0003176 | Aortic valve development | 3/86 | 32/18866 | 0.000412269 | 0.022856978 | 0.018529411 | GATA3/SMAD6/BMPR2 | 3 |
| GO:0060411 | Cardiac septum morphogenesis | 4/86 | 77/18866 | 0.00042271 | 0.022903202 | 0.018566884 | SMAD6/TGFB2/SOX4/BMPR2 | 4 |
| GO:0010632 | Regulation of epithelial cell migration | 7/86 | 301/18866 | 0.000449424 | 0.023809483 | 0.019301576 | GATA3/SASH1/TGFB2/SEMA3A/HDAC9/BMPR2/ITGB3 | 7 |
| GO:0021675 | Nerve development | 4/86 | 79/18866 | 0.000466089 | 0.024155573 | 0.01958214 | GABRB3/BDNF/SEMA3A/SLITRK6 | 4 |
| GO:0032232 | Negative regulation of actin filament bundle assembly | 3/86 | 34/18866 | 0.000494123 | 0.025063604 | 0.020318252 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0010769 | Regulation of cell morphogenesis involved in differentiation | 7/86 | 310/18866 | 0.000535603 | 0.025683957 | 0.020821152 | PPP1R9A/SKIL/BDNF/SEMA3A/BMPR2/MAP2/NEDD9 | 7 |
| GO:0090287 | Regulation of cellular response to growth factor stimulus | 7/86 | 310/18866 | 0.000535603 | 0.025683957 | 0.020821152 | SORL1/FST/GATA3/SKIL/SMAD6/BMPR2/ITGB3 | 7 |
| GO:0110111 | Negative regulation of animal organ morphogenesis | 3/86 | 35/18866 | 0.000538674 | 0.025683957 | 0.020821152 | GATA3/TGFB2/BMPR2 | 3 |
| GO:0002088 | Lens development in camera-type eye | 4/86 | 83/18866 | 0.000562221 | 0.026281074 | 0.021305215 | SLC7A11/GATA3/SKIL/SLITRK6 | 4 |
| GO:0000289 | Nuclear-transcribed mRNA poly(A) tail shortening | 3/86 | 36/18866 | 0.000585716 | 0.026852821 | 0.021768712 | CPEB3/TNRC6C/CNOT6L | 3 |
| GO:0016331 | Morphogenesis of embryonic epithelium | 5/86 | 151/18866 | 0.000635718 | 0.028595307 | 0.023181289 | GATA3/TGFB2/SOX4/MTHFR/TP63 | 5 |
| GO:0001942 | Hair follicle development | 4/86 | 87/18866 | 0.00067167 | 0.029652983 | 0.024038713 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:0007050 | Cell cycle arrest | 6/86 | 234/18866 | 0.000702266 | 0.030276819 | 0.024544437 | SKIL/TGFB2/SOX4/JMY/TP53INP1/CNOT6L | 6 |
| GO:0022404 | Molting cycle process | 4/86 | 89/18866 | 0.000731697 | 0.030276819 | 0.024544437 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:0022405 | Hair cycle process | 4/86 | 89/18866 | 0.000731697 | 0.030276819 | 0.024544437 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:1902904 | Negative regulation of supramolecular fiber organization | 5/86 | 156/18866 | 0.0007366 | 0.030276819 | 0.024544437 | PPP1R9A/CGNL1/TTBK2/ARHGAP28/MAP2 | 5 |
| GO:0098773 | Skin epidermis development | 4/86 | 90/18866 | 0.000763091 | 0.030834037 | 0.024996155 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:1902895 | Positive regulation of pri-miRNA transcription by RNA polymerase II | 3/86 | 40/18866 | 0.000799907 | 0.031782969 | 0.025765423 | GATA3/SMAD6/TGFB2 | 3 |
| GO:0048286 | Lung alveolus development | 3/86 | 41/18866 | 0.000860228 | 0.03260155 | 0.026429021 | SLC7A11/ATP7A/BMPR2 | 3 |
| GO:0014909 | Smooth muscle cell migration | 4/86 | 93/18866 | 0.000862978 | 0.03260155 | 0.026429021 | SORL1/ATP7A/PRKG1/ITGB3 | 4 |
| GO:0009267 | Cellular response to starvation | 5/86 | 163/18866 | 0.000897377 | 0.03260155 | 0.026429021 | NUAK1/SLC38A2/GABARAPL1/INHBB/BMPR2 | 5 |
| GO:0051494 | Negative regulation of cytoskeleton organization | 5/86 | 163/18866 | 0.000897377 | 0.03260155 | 0.026429021 | PPP1R9A/CGNL1/TTBK2/ARHGAP28/MAP2 | 5 |
| GO:0045713 | Low-density lipoprotein particle receptor biosynthetic process | 2/86 | 10/18866 | 0.00090256 | 0.03260155 | 0.026429021 | ITGAV/ITGB3 | 2 |
| GO:1904526 | Regulation of microtubule binding | 2/86 | 10/18866 | 0.00090256 | 0.03260155 | 0.026429021 | TTBK2/MAP2 | 2 |
| GO:0051100 | Negative regulation of binding | 5/86 | 169/18866 | 0.001054847 | 0.037420693 | 0.030335744 | SORL1/RSF1/TTBK2/ARHGAP28/MAP2 | 5 |
| GO:0050673 | Epithelial cell proliferation | 8/86 | 453/18866 | 0.001072913 | 0.037420693 | 0.030335744 | FST/COL8A1/GATA3/TGFB2/ATP7A/BMPR2/ITGB3/TP63 | 8 |
| GO:0098917 | Retrograde transsynaptic signaling | 2/86 | 11/18866 | 0.001099862 | 0.037420693 | 0.030335744 | BDNF/PLCB1 | 2 |
| GO:0032924 | Activin receptor signaling pathway | 3/86 | 45/18866 | 0.001130155 | 0.037420693 | 0.030335744 | FST/INHBB/BMPR2 | 3 |
| GO:0046189 | Phenol-containing compound biosynthetic process | 3/86 | 45/18866 | 0.001130155 | 0.037420693 | 0.030335744 | SLC7A11/GATA3/TGFB2 | 3 |
| GO:0060412 | Ventricular septum morphogenesis | 3/86 | 45/18866 | 0.001130155 | 0.037420693 | 0.030335744 | TGFB2/SOX4/BMPR2 | 3 |
| GO:0060840 | Artery development | 4/86 | 102/18866 | 0.001217645 | 0.038883859 | 0.031521885 | SMAD6/TGFB2/SOX4/BMPR2 | 4 |
| GO:0007178 | Transmembrane receptor protein serine/threonine kinase signaling pathway | 7/86 | 359/18866 | 0.001263006 | 0.038883859 | 0.031521885 | SORL1/FST/SKIL/SMAD6/TGFB2/INHBB/BMPR2 | 7 |
| GO:0050919 | Negative chemotaxis | 3/86 | 47/18866 | 0.001282991 | 0.038883859 | 0.031521885 | SEMA3A/ITGAV/ITGB3 | 3 |
| GO:0070997 | Neuron death | 7/86 | 360/18866 | 0.001283364 | 0.038883859 | 0.031521885 | SORL1/SLC7A11/GATA3/GABRB3/TGFB2/BDNF/TP63 | 7 |
| GO:0051798 | Positive regulation of hair follicle development | 2/86 | 12/18866 | 0.001315929 | 0.038883859 | 0.031521885 | FST/TGFB2 | 2 |
| GO:0060213 | Positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2/86 | 12/18866 | 0.001315929 | 0.038883859 | 0.031521885 | CPEB3/TNRC6C | 2 |
| GO:0010862 | Positive regulation of pathway-restricted SMAD protein phosphorylation | 3/86 | 48/18866 | 0.001364044 | 0.038883859 | 0.031521885 | TGFB2/INHBB/BMPR2 | 3 |
| GO:0072331 | Signal transduction by p53 class mediator | 6/86 | 267/18866 | 0.001386923 | 0.038883859 | 0.031521885 | NUAK1/SOX4/JMY/TP53INP1/TP63/CNOT6L | 6 |
| GO:0010631 | Epithelial cell migration | 7/86 | 365/18866 | 0.001389051 | 0.038883859 | 0.031521885 | GATA3/SASH1/TGFB2/SEMA3A/HDAC9/BMPR2/ITGB3 | 7 |
| GO:0014812 | Muscle cell migration | 4/86 | 106/18866 | 0.001403922 | 0.038883859 | 0.031521885 | SORL1/ATP7A/PRKG1/ITGB3 | 4 |
| GO:0008361 | Regulation of cell size | 5/86 | 181/18866 | 0.001430229 | 0.038883859 | 0.031521885 | BDNF/SEMA3A/ATP7A/BMPR2/MAP2 | 5 |
| GO:0048736 | Appendage development | 5/86 | 181/18866 | 0.001430229 | 0.038883859 | 0.031521885 | SLC7A11/TGFB2/SOX4/BMPR2/TP63 | 5 |
| GO:0060173 | Limb development | 5/86 | 181/18866 | 0.001430229 | 0.038883859 | 0.031521885 | SLC7A11/TGFB2/SOX4/BMPR2/TP63 | 5 |
| GO:0051098 | Regulation of binding | 7/86 | 367/18866 | 0.001433187 | 0.038883859 | 0.031521885 | SORL1/GATA3/RSF1/BDNF/TTBK2/ARHGAP28/MAP2 | 7 |
| GO:0090132 | Epithelium migration | 7/86 | 368/18866 | 0.001455662 | 0.038883859 | 0.031521885 | GATA3/SASH1/TGFB2/SEMA3A/HDAC9/BMPR2/ITGB3 | 7 |
| GO:0061014 | Positive regulation of mRNA catabolic process | 3/86 | 50/18866 | 0.001535648 | 0.038883859 | 0.031521885 | CPEB3/TNRC6C/CNOT6L | 3 |
| GO:0010745 | Negative regulation of macrophage derived foam cell differentiation | 2/86 | 13/18866 | 0.001550587 | 0.038883859 | 0.031521885 | ITGAV/ITGB3 | 2 |
| GO:0042415 | Norepinephrine metabolic process | 2/86 | 13/18866 | 0.001550587 | 0.038883859 | 0.031521885 | GATA3/ATP7A | 2 |
| GO:0042635 | Positive regulation of hair cycle | 2/86 | 13/18866 | 0.001550587 | 0.038883859 | 0.031521885 | FST/TGFB2 | 2 |
| GO:1903651 | Positive regulation of cytoplasmic transport | 2/86 | 13/18866 | 0.001550587 | 0.038883859 | 0.031521885 | SORL1/MAP2 | 2 |
| GO:0018958 | Phenol-containing compound metabolic process | 4/86 | 109/18866 | 0.001556068 | 0.038883859 | 0.031521885 | SLC7A11/GATA3/TGFB2/ATP7A | 4 |
| GO:0007409 | Axonogenesis | 8/86 | 482/18866 | 0.001590594 | 0.038883859 | 0.031521885 | GATA3/SKIL/ETV1/BDNF/SEMA3A/SLITRK6/BMPR2/MAP2 | 8 |
| GO:0090130 | Tissue migration | 7/86 | 374/18866 | 0.00159637 | 0.038883859 | 0.031521885 | GATA3/SASH1/TGFB2/SEMA3A/HDAC9/BMPR2/ITGB3 | 7 |
| GO:0051051 | Negative regulation of transport | 8/86 | 483/18866 | 0.001611458 | 0.038883859 | 0.031521885 | PPP1R9A/SESTD1/ATP7A/HDAC9/ITGAV/INHBB/PACSIN1/ITGB3 | 8 |
| GO:0050770 | Regulation of axonogenesis | 5/86 | 186/18866 | 0.001612647 | 0.038883859 | 0.031521885 | SKIL/BDNF/SEMA3A/BMPR2/MAP2 | 5 |
| GO:0090102 | Cochlea development | 3/86 | 51/18866 | 0.001626288 | 0.038883859 | 0.031521885 | GATA3/GABRB3/SLITRK6 | 3 |
| GO:1902893 | Regulation of pri-miRNA transcription by RNA polymerase II | 3/86 | 51/18866 | 0.001626288 | 0.038883859 | 0.031521885 | GATA3/SMAD6/TGFB2 | 3 |
| GO:0042303 | Molting cycle | 4/86 | 111/18866 | 0.001663655 | 0.038883859 | 0.031521885 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:0042633 | Hair cycle | 4/86 | 111/18866 | 0.001663655 | 0.038883859 | 0.031521885 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:0061387 | Regulation of extent of cell growth | 4/86 | 111/18866 | 0.001663655 | 0.038883859 | 0.031521885 | BDNF/SEMA3A/BMPR2/MAP2 | 4 |
| GO:0030514 | Negative regulation of BMP signaling pathway | 3/86 | 52/18866 | 0.001720211 | 0.039815365 | 0.032277027 | SORL1/SKIL/SMAD6 | 3 |
| GO:0007548 | Sex differentiation | 6/86 | 280/18866 | 0.001764948 | 0.040458044 | 0.032798026 | FST/GATA3/TGFB2/SEMA3A/INHBB/TP63 | 6 |
| GO:0060211 | Regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2/86 | 14/18866 | 0.001803668 | 0.040875705 | 0.03313661 | CPEB3/TNRC6C | 2 |
| GO:0061614 | Pri-miRNA transcription by RNA polymerase II | 3/86 | 53/18866 | 0.00181746 | 0.040875705 | 0.03313661 | GATA3/SMAD6/TGFB2 | 3 |
| GO:0006584 | Catecholamine metabolic process | 3/86 | 54/18866 | 0.001918077 | 0.042339775 | 0.034323484 | GATA3/TGFB2/ATP7A | 3 |
| GO:0009712 | Catechol-containing compound metabolic process | 3/86 | 54/18866 | 0.001918077 | 0.042339775 | 0.034323484 | GATA3/TGFB2/ATP7A | 3 |
| GO:0030900 | Forebrain development | 7/86 | 391/18866 | 0.002053275 | 0.044167892 | 0.03580548 | SLC7A11/BCAN/SEMA3A/ATP7A/SLC38A2/PLCB1/PRKG1 | 7 |
| GO:0048839 | Inner ear development | 5/86 | 197/18866 | 0.002073551 | 0.044167892 | 0.03580548 | GATA3/GABRB3/TGFB2/BDNF/SLITRK6 | 5 |
| GO:0007638 | Mechanosensory behavior | 2/86 | 15/18866 | 0.002075002 | 0.044167892 | 0.03580548 | ETV1/SLITRK6 | 2 |
| GO:0050746 | Regulation of lipoprotein metabolic process | 2/86 | 15/18866 | 0.002075002 | 0.044167892 | 0.03580548 | ITGAV/ITGB3 | 2 |
| GO:0010976 | Positive regulation of neuron projection development | 6/86 | 290/18866 | 0.002105428 | 0.044418936 | 0.036008992 | CPEB3/PPP1R9A/SKIL/BDNF/BMPR2/PACSIN1 | 6 |
| GO:0031346 | Positive regulation of cell projection organization | 7/86 | 394/18866 | 0.002143474 | 0.044824937 | 0.036338124 | CPEB3/PPP1R9A/SKIL/BDNF/ATP7A/BMPR2/PACSIN1 | 7 |
| GO:0007613 | Memory | 4/86 | 121/18866 | 0.002280062 | 0.047266679 | 0.038317566 | CPEB3/ATXN1/BDNF/PLCB1 | 4 |
| GO:0042035 | Regulation of cytokine biosynthetic process | 2/86 | 16/18866 | 0.002364421 | 0.048592932 | 0.039392716 | GATA3/INHBB | 2 |
| GO:0048675 | Axon extension | 4/86 | 123/18866 | 0.00241989 | 0.049307834 | 0.039972264 | BDNF/SEMA3A/BMPR2/MAP2 | 4 |
| GO:0042594 | Response to starvation | 5/86 | 206/18866 | 0.002516912 | 0.050850145 | 0.041222566 | NUAK1/SLC38A2/GABARAPL1/INHBB/BMPR2 | 5 |
| GO:0001838 | Embryonic epithelial tube formation | 4/86 | 125/18866 | 0.002565513 | 0.051396495 | 0.041665474 | GATA3/TGFB2/SOX4/MTHFR | 4 |
| GO:0035904 | Aorta development | 3/86 | 60/18866 | 0.002594751 | 0.051549046 | 0.041789142 | SMAD6/TGFB2/SOX4 | 3 |
| GO:0003184 | Pulmonary valve morphogenesis | 2/86 | 17/18866 | 0.00267176 | 0.051784349 | 0.041979895 | SMAD6/TGFB2 | 2 |
| GO:0006750 | Glutathione biosynthetic process | 2/86 | 17/18866 | 0.00267176 | 0.051784349 | 0.041979895 | SLC7A11/CHAC1 | 2 |
| GO:1900363 | Regulation of mRNA polyadenylation | 2/86 | 17/18866 | 0.00267176 | 0.051784349 | 0.041979895 | CPEB3/CCNT1 | 2 |
| GO:0001704 | Formation of primary germ layer | 4/86 | 127/18866 | 0.002717051 | 0.052237505 | 0.042347253 | COL8A1/ITGAV/BMPR2/ITGB3 | 4 |
| GO:0070527 | Platelet aggregation | 3/86 | 62/18866 | 0.002849026 | 0.054336625 | 0.044048942 | SLC7A11/PRKG1/ITGB3 | 3 |
| GO:0060080 | Inhibitory postsynaptic potential | 2/86 | 18/18866 | 0.002996851 | 0.055816359 | 0.045248514 | GABRB3/BDNF | 2 |
| GO:0061298 | Retina vasculature development in camera-type eye | 2/86 | 18/18866 | 0.002996851 | 0.055816359 | 0.045248514 | CLIC4/BMPR2 | 2 |
| GO:1900153 | Positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2/86 | 18/18866 | 0.002996851 | 0.055816359 | 0.045248514 | CPEB3/TNRC6C | 2 |
| GO:0072175 | Epithelial tube formation | 4/86 | 133/18866 | 0.003208333 | 0.058835885 | 0.047696346 | GATA3/TGFB2/SOX4/MTHFR | 4 |
| GO:0090101 | Negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 4/86 | 133/18866 | 0.003208333 | 0.058835885 | 0.047696346 | SORL1/FST/SKIL/SMAD6 | 4 |
| GO:0019184 | Nonribosomal peptide biosynthetic process | 2/86 | 19/18866 | 0.003339532 | 0.060550663 | 0.049086461 | SLC7A11/CHAC1 | 2 |
| GO:0045785 | Positive regulation of cell adhesion | 7/86 | 428/18866 | 0.003395248 | 0.060550663 | 0.049086461 | MAGI1/COL8A1/GATA3/TGFB2/SOX4/ITGAV/NEDD9 | 7 |
| GO:0042490 | Mechanoreceptor differentiation | 3/86 | 66/18866 | 0.00340238 | 0.060550663 | 0.049086461 | GABRB3/BDNF/SLITRK6 | 3 |
| GO:0031669 | Cellular response to nutrient levels | 5/86 | 221/18866 | 0.003403435 | 0.060550663 | 0.049086461 | NUAK1/SLC38A2/GABARAPL1/INHBB/BMPR2 | 5 |
| GO:1901214 | Regulation of neuron death | 6/86 | 321/18866 | 0.003481234 | 0.061476012 | 0.049836611 | SORL1/SLC7A11/GATA3/GABRB3/TGFB2/BDNF | 6 |
| GO:0008406 | Gonad development | 5/86 | 223/18866 | 0.00353664 | 0.06199522 | 0.050257517 | FST/GATA3/TGFB2/SEMA3A/INHBB | 5 |
| GO:0043583 | Ear development | 5/86 | 224/18866 | 0.003604631 | 0.062552759 | 0.050709496 | GATA3/GABRB3/TGFB2/BDNF/SLITRK6 | 5 |
| GO:0007015 | Actin filament organization | 7/86 | 434/18866 | 0.003664496 | 0.062552759 | 0.050709496 | PPP1R9A/NEBL/CGNL1/ARHGAP28/PACSIN1/JMY/NEDD9 | 7 |
| GO:0002320 | Lymphoid progenitor cell differentiation | 2/86 | 20/18866 | 0.003699639 | 0.062552759 | 0.050709496 | GATA3/SOX4 | 2 |
| GO:0042089 | Cytokine biosynthetic process | 2/86 | 20/18866 | 0.003699639 | 0.062552759 | 0.050709496 | GATA3/INHBB | 2 |
| GO:1900151 | Regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2/86 | 20/18866 | 0.003699639 | 0.062552759 | 0.050709496 | CPEB3/TNRC6C | 2 |
| GO:0045137 | Development of primary sexual characteristics | 5/86 | 229/18866 | 0.003958763 | 0.065577145 | 0.053161267 | FST/GATA3/TGFB2/SEMA3A/INHBB | 5 |
| GO:0001655 | Urogenital system development | 6/86 | 330/18866 | 0.003983793 | 0.065577145 | 0.053161267 | GATA3/SMAD6/TGFB2/SOX4/BDNF/TP63 | 6 |
| GO:0009713 | Catechol-containing compound biosynthetic process | 2/86 | 21/18866 | 0.004077009 | 0.065577145 | 0.053161267 | GATA3/TGFB2 | 2 |
| GO:0042107 | Cytokine metabolic process | 2/86 | 21/18866 | 0.004077009 | 0.065577145 | 0.053161267 | GATA3/INHBB | 2 |
| GO:0042423 | Catecholamine biosynthetic process | 2/86 | 21/18866 | 0.004077009 | 0.065577145 | 0.053161267 | GATA3/TGFB2 | 2 |
| GO:0051797 | Regulation of hair follicle development | 2/86 | 21/18866 | 0.004077009 | 0.065577145 | 0.053161267 | FST/TGFB2 | 2 |
| GO:0060065 | Uterus development | 2/86 | 21/18866 | 0.004077009 | 0.065577145 | 0.053161267 | GATA3/TGFB2 | 2 |
| GO:0048608 | Reproductive structure development | 7/86 | 443/18866 | 0.004098572 | 0.065577145 | 0.053161267 | FST/GATA3/TGFB2/SEMA3A/INHBB/BMPR2/TP63 | 7 |
| GO:0015800 | Acidic amino acid transport | 3/86 | 71/18866 | 0.004180801 | 0.066006816 | 0.053509587 | SLC7A11/BDNF/SLC38A2 | 3 |
| GO:0033627 | Cell adhesion mediated by integrin | 3/86 | 71/18866 | 0.004180801 | 0.066006816 | 0.053509587 | TGFB2/ITGAV/ITGB3 | 3 |
| GO:0061458 | Reproductive system development | 7/86 | 447/18866 | 0.004303588 | 0.06749838 | 0.05471875 | FST/GATA3/TGFB2/SEMA3A/INHBB/BMPR2/TP63 | 7 |
| GO:0070988 | Demethylation | 3/86 | 72/18866 | 0.004348359 | 0.067754826 | 0.054926642 | GATA3/TET2/JMJD1C | 3 |
| GO:0043254 | Regulation of protein-containing complex assembly | 7/86 | 449/18866 | 0.004408972 | 0.068253172 | 0.055330636 | SORL1/PPP1R9A/SMAD6/ARHGAP28/ATF7IP/JMY/MAP2 | 7 |
| GO:0010888 | Negative regulation of lipid storage | 2/86 | 22/18866 | 0.004471481 | 0.068774263 | 0.055753068 | ITGAV/ITGB3 | 2 |
| GO:0003208 | Cardiac ventricle morphogenesis | 3/86 | 73/18866 | 0.004519944 | 0.069074013 | 0.055996065 | GATA3/TGFB2/SOX4 | 3 |
| GO:0051047 | Positive regulation of secretion | 6/86 | 340/18866 | 0.00460332 | 0.069900087 | 0.056665737 | SORL1/SYTL2/TGFB2/SOX4/MYO18A/INHBB | 6 |
| GO:0010594 | Regulation of endothelial cell migration | 5/86 | 238/18866 | 0.004657999 | 0.070185555 | 0.056897156 | GATA3/SASH1/HDAC9/BMPR2/ITGB3 | 5 |
| GO:0050804 | Modulation of chemical synaptic transmission | 7/86 | 454/18866 | 0.004681 | 0.070185555 | 0.056897156 | CPEB3/PPP1R9A/FBXL20/SLC7A11/SLC24A1/BDNF/PLCB1 | 7 |
| GO:0099177 | Regulation of trans-synaptic signaling | 7/86 | 455/18866 | 0.004736897 | 0.070579766 | 0.05721673 | CPEB3/PPP1R9A/FBXL20/SLC7A11/SLC24A1/BDNF/PLCB1 | 7 |
| GO:0048844 | Artery morphogenesis | 3/86 | 75/18866 | 0.004875303 | 0.070980628 | 0.057541696 | TGFB2/SOX4/BMPR2 | 3 |
| GO:0050805 | Negative regulation of synaptic transmission | 3/86 | 75/18866 | 0.004875303 | 0.070980628 | 0.057541696 | PPP1R9A/SLC24A1/BDNF | 3 |
| GO:1900006 | Positive regulation of dendrite development | 3/86 | 75/18866 | 0.004875303 | 0.070980628 | 0.057541696 | CPEB3/PPP1R9A/PACSIN1 | 3 |
| GO:0032799 | Low-density lipoprotein receptor particle metabolic process | 2/86 | 23/18866 | 0.004882896 | 0.070980628 | 0.057541696 | ITGAV/ITGB3 | 2 |
| GO:0035148 | Tube formation | 4/86 | 150/18866 | 0.004922269 | 0.071119327 | 0.057654135 | GATA3/TGFB2/SOX4/MTHFR | 4 |
| GO:0051402 | Neuron apoptotic process | 5/86 | 245/18866 | 0.005259584 | 0.075535237 | 0.06123397 | GATA3/GABRB3/TGFB2/BDNF/TP63 | 5 |
| GO:0010869 | Regulation of receptor biosynthetic process | 2/86 | 24/18866 | 0.005311093 | 0.075818242 | 0.061463393 | ITGAV/ITGB3 | 2 |
| GO:0050708 | Regulation of protein secretion | 6/86 | 352/18866 | 0.005437537 | 0.076277029 | 0.061835316 | SORL1/TGFB2/SOX4/HDAC9/MYO18A/INHBB | 6 |
| GO:0000288 | Nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3/86 | 78/18866 | 0.005439218 | 0.076277029 | 0.061835316 | CPEB3/TNRC6C/CNOT6L | 3 |
| GO:0060395 | SMAD protein signal transduction | 3/86 | 78/18866 | 0.005439218 | 0.076277029 | 0.061835316 | SMAD6/TGFB2/INHBB | 3 |
| GO:0009636 | Response to toxic substance | 5/86 | 250/18866 | 0.005721706 | 0.079503569 | 0.064450968 | PPP1R9A/AHR/SLC7A11/ATP7A/TP53INP1 | 5 |
| GO:0010770 | Positive regulation of cell morphogenesis involved in differentiation | 4/86 | 157/18866 | 0.00577791 | 0.079503569 | 0.064450968 | SKIL/BDNF/BMPR2/NEDD9 | 4 |
| GO:0051017 | Actin filament bundle assembly | 4/86 | 157/18866 | 0.00577791 | 0.079503569 | 0.064450968 | PPP1R9A/CGNL1/ARHGAP28/NEDD9 | 4 |
| GO:0031667 | Response to nutrient levels | 7/86 | 473/18866 | 0.005832 | 0.079503569 | 0.064450968 | SORL1/NUAK1/MTHFR/SLC38A2/GABARAPL1/INHBB/BMPR2 | 7 |
| GO:0003151 | Outflow tract morphogenesis | 3/86 | 80/18866 | 0.005836042 | 0.079503569 | 0.064450968 | SMAD6/TGFB2/BMPR2 | 3 |
| GO:0031668 | Cellular response to extracellular stimulus | 5/86 | 253/18866 | 0.006012367 | 0.081440239 | 0.066020964 | NUAK1/SLC38A2/GABARAPL1/INHBB/BMPR2 | 5 |
| GO:0021884 | Forebrain neuron development | 2/86 | 26/18866 | 0.006217208 | 0.082775094 | 0.067103088 | SEMA3A/ATP7A | 2 |
| GO:1903649 | Regulation of cytoplasmic transport | 2/86 | 26/18866 | 0.006217208 | 0.082775094 | 0.067103088 | SORL1/MAP2 | 2 |
| GO:0021954 | Central nervous system neuron development | 3/86 | 82/18866 | 0.006249797 | 0.082775094 | 0.067103088 | SEMA3A/ATP7A/MAP2 | 3 |
| GO:1903313 | Positive regulation of mRNA metabolic process | 3/86 | 82/18866 | 0.006249797 | 0.082775094 | 0.067103088 | CPEB3/TNRC6C/CNOT6L | 3 |
| GO:0061572 | Actin filament bundle organization | 4/86 | 161/18866 | 0.006308804 | 0.08305588 | 0.067330711 | PPP1R9A/CGNL1/ARHGAP28/NEDD9 | 4 |
| GO:0001667 | Ameboidal-type cell migration | 7/86 | 481/18866 | 0.006375514 | 0.08305588 | 0.067330711 | GATA3/SASH1/TGFB2/SEMA3A/HDAC9/BMPR2/ITGB3 | 7 |
| GO:0016569 | Covalent chromatin modification | 7/86 | 481/18866 | 0.006375514 | 0.08305588 | 0.067330711 | GATA3/RSF1/MTHFR/HDAC9/ATF7IP/TET2/JMJD1C | 7 |
| GO:2000146 | Negative regulation of cell motility | 6/86 | 365/18866 | 0.006461198 | 0.083286412 | 0.067517597 | GATA3/CLIC4/SEMA3A/PLCB1/PRKG1/TP53INP1 | 6 |
| GO:2000243 | Positive regulation of reproductive process | 3/86 | 83/18866 | 0.006463081 | 0.083286412 | 0.067517597 | SEMA3A/INHBB/PLCB1 | 3 |
| GO:0003007 | Heart morphogenesis | 5/86 | 258/18866 | 0.006519717 | 0.083564546 | 0.067743071 | GATA3/SMAD6/TGFB2/SOX4/BMPR2 | 5 |
| GO:0021537 | Telencephalon development | 5/86 | 259/18866 | 0.006624687 | 0.084002275 | 0.068097923 | SLC7A11/BCAN/SEMA3A/SLC38A2/PLCB1 | 5 |
| GO:0050769 | Positive regulation of neurogenesis | 7/86 | 485/18866 | 0.006661076 | 0.084002275 | 0.068097923 | CPEB3/PPP1R9A/SKIL/BDNF/SEMA3A/BMPR2/PACSIN1 | 7 |
| GO:0007214 | Gamma-aminobutyric acid signaling pathway | 2/86 | 27/18866 | 0.006694812 | 0.084002275 | 0.068097923 | GABRB3/BDNF | 2 |
| GO:0072337 | Modified amino acid transport | 2/86 | 27/18866 | 0.006694812 | 0.084002275 | 0.068097923 | SLC7A11/SLC38A2 | 2 |
| GO:0007611 | Learning or memory | 5/86 | 260/18866 | 0.006730839 | 0.084012142 | 0.068105922 | CPEB3/SLC7A11/ATXN1/BDNF/PLCB1 | 5 |
| GO:0014910 | Regulation of smooth muscle cell migration | 3/86 | 86/18866 | 0.007128822 | 0.086118398 | 0.069813396 | SORL1/ATP7A/PRKG1 | 3 |
| GO:0034109 | Homotypic cell-cell adhesion | 3/86 | 86/18866 | 0.007128822 | 0.086118398 | 0.069813396 | SLC7A11/PRKG1/ITGB3 | 3 |
| GO:0050772 | Positive regulation of axonogenesis | 3/86 | 86/18866 | 0.007128822 | 0.086118398 | 0.069813396 | SKIL/BDNF/BMPR2 | 3 |
| GO:1902903 | Regulation of supramolecular fiber organization | 6/86 | 373/18866 | 0.007157109 | 0.086118398 | 0.069813396 | PPP1R9A/CGNL1/TTBK2/ARHGAP28/JMY/MAP2 | 6 |
| GO:0003180 | Aortic valve morphogenesis | 2/86 | 28/18866 | 0.007188574 | 0.086118398 | 0.069813396 | GATA3/SMAD6 | 2 |
| GO:0031440 | Regulation of mRNA 3′-end processing | 2/86 | 28/18866 | 0.007188574 | 0.086118398 | 0.069813396 | CPEB3/CCNT1 | 2 |
| GO:0032800 | Receptor biosynthetic process | 2/86 | 28/18866 | 0.007188574 | 0.086118398 | 0.069813396 | ITGAV/ITGB3 | 2 |
| GO:0080111 | DNA demethylation | 2/86 | 28/18866 | 0.007188574 | 0.086118398 | 0.069813396 | GATA3/TET2 | 2 |
| GO:0032874 | Positive regulation of stress-activated MAPK cascade | 4/86 | 170/18866 | 0.007619707 | 0.090826908 | 0.073630433 | SASH1/TGFB2/SEMA3A/PLCB1 | 4 |
| GO:0042634 | Regulation of hair cycle | 2/86 | 29/18866 | 0.007698341 | 0.091302546 | 0.074016017 | FST/TGFB2 | 2 |
| GO:0022604 | Regulation of cell morphogenesis | 7/86 | 499/18866 | 0.007736206 | 0.091302546 | 0.074016017 | PPP1R9A/SKIL/BDNF/SEMA3A/BMPR2/MAP2/NEDD9 | 7 |
| GO:0045666 | Positive regulation of neuron differentiation | 6/86 | 380/18866 | 0.007809358 | 0.091370068 | 0.074070754 | CPEB3/PPP1R9A/SKIL/BDNF/BMPR2/PACSIN1 | 6 |
| GO:0002791 | Regulation of peptide secretion | 6/86 | 381/18866 | 0.007905929 | 0.091370068 | 0.074070754 | SORL1/TGFB2/SOX4/HDAC9/MYO18A/INHBB | 6 |
| GO:0050714 | Positive regulation of protein secretion | 4/86 | 172/18866 | 0.007933559 | 0.091370068 | 0.074070754 | SORL1/TGFB2/SOX4/MYO18A | 4 |
| GO:0070304 | Positive regulation of stress-activated protein kinase signaling cascade | 4/86 | 172/18866 | 0.007933559 | 0.091370068 | 0.074070754 | SASH1/TGFB2/SEMA3A/PLCB1 | 4 |
| GO:1990138 | Neuron projection extension | 4/86 | 172/18866 | 0.007933559 | 0.091370068 | 0.074070754 | BDNF/SEMA3A/BMPR2/MAP2 | 4 |
| GO:0045682 | Regulation of epidermis development | 3/86 | 91/18866 | 0.008325904 | 0.094971077 | 0.076989976 | FST/TGFB2/TP63 | 3 |
| GO:0051492 | Regulation of stress fiber assembly | 3/86 | 91/18866 | 0.008325904 | 0.094971077 | 0.076989976 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0060292 | Long-term synaptic depression | 2/86 | 31/18866 | 0.008765276 | 0.099506758 | 0.080666905 | PPP1R9A/SLC24A1 | 2 |
| GO:0045778 | Positive regulation of ossification | 3/86 | 94/18866 | 0.009097485 | 0.102722925 | 0.083274148 | TGFB2/BMPR2/TP63 | 3 |
| GO:1901796 | Regulation of signal transduction by p53 class mediator | 4/86 | 180/18866 | 0.009273809 | 0.102722925 | 0.083274148 | NUAK1/JMY/TP53INP1/TP63 | 4 |
| GO:0010743 | Regulation of macrophage derived foam cell differentiation | 2/86 | 32/18866 | 0.009322144 | 0.102722925 | 0.083274148 | ITGAV/ITGB3 | 2 |
| GO:0048841 | Regulation of axon extension involved in axon guidance | 2/86 | 32/18866 | 0.009322144 | 0.102722925 | 0.083274148 | SEMA3A/BMPR2 | 2 |
| GO:0061157 | mRNA destabilization | 2/86 | 32/18866 | 0.009322144 | 0.102722925 | 0.083274148 | CPEB3/CNOT6L | 2 |
| GO:0030198 | Extracellular matrix organization | 6/86 | 395/18866 | 0.009350199 | 0.102722925 | 0.083274148 | COL8A1/TGFB2/BCAN/ATP7A/ITGAV/ITGB3 | 6 |
| GO:0050678 | Regulation of epithelial cell proliferation | 6/86 | 395/18866 | 0.009350199 | 0.102722925 | 0.083274148 | GATA3/TGFB2/ATP7A/BMPR2/ITGB3/TP63 | 6 |
| GO:0043062 | Extracellular structure organization | 6/86 | 396/18866 | 0.009460121 | 0.103453798 | 0.083866643 | COL8A1/TGFB2/BCAN/ATP7A/ITGAV/ITGB3 | 6 |
| GO:0001822 | Kidney development | 5/86 | 283/18866 | 0.009514131 | 0.103569356 | 0.083960322 | GATA3/SMAD6/TGFB2/SOX4/BDNF | 5 |
| GO:0040013 | Negative regulation of locomotion | 6/86 | 397/18866 | 0.009570966 | 0.103635943 | 0.084014302 | GATA3/CLIC4/SEMA3A/PLCB1/PRKG1/TP53INP1 | 6 |
| GO:0090288 | Negative regulation of cellular response to growth factor stimulus | 4/86 | 182/18866 | 0.009630517 | 0.103635943 | 0.084014302 | SORL1/GATA3/SKIL/SMAD6 | 4 |
| GO:0007411 | Axon guidance | 5/86 | 284/18866 | 0.009650662 | 0.103635943 | 0.084014302 | GATA3/ETV1/BDNF/SEMA3A/BMPR2 | 5 |
| GO:0097485 | Neuron projection guidance | 5/86 | 285/18866 | 0.00978854 | 0.103806173 | 0.084152302 | GATA3/ETV1/BDNF/SEMA3A/BMPR2 | 5 |
| GO:0055001 | Muscle cell development | 4/86 | 183/18866 | 0.009812177 | 0.103806173 | 0.084152302 | NEBL/PGM5/HDAC9/ANK2 | 4 |
| GO:2000758 | Positive regulation of peptidyllysine acetylation | 2/86 | 33/18866 | 0.00989441 | 0.103806173 | 0.084152302 | GATA3/SOX4 | 2 |
| GO:0051271 | Negative regulation of cellular component movement | 6/86 | 400/18866 | 0.009909083 | 0.103806173 | 0.084152302 | GATA3/CLIC4/SEMA3A/PLCB1/PRKG1/TP53INP1 | 6 |
| GO:0030516 | Regulation of axon extension | 3/86 | 97/18866 | 0.009909621 | 0.103806173 | 0.084152302 | SEMA3A/BMPR2/MAP2 | 3 |
| GO:0043542 | Endothelial cell migration | 5/86 | 286/18866 | 0.009927772 | 0.103806173 | 0.084152302 | GATA3/SASH1/HDAC9/BMPR2/ITGB3 | 5 |
| GO:0007416 | Synapse assembly | 4/86 | 184/18866 | 0.009996053 | 0.104063714 | 0.084361082 | PPP1R9A/GABRB3/BDNF/SLITRK6 | 4 |
| GO:0001657 | Ureteric bud development | 3/86 | 98/18866 | 0.010189417 | 0.104705042 | 0.084880986 | GATA3/SMAD6/BDNF | 3 |
| GO:0006835 | Dicarboxylic acid transport | 3/86 | 98/18866 | 0.010189417 | 0.104705042 | 0.084880986 | SLC7A11/BDNF/SLC38A2 | 3 |
| GO:0044728 | DNA methylation or demethylation | 3/86 | 98/18866 | 0.010189417 | 0.104705042 | 0.084880986 | GATA3/ATF7IP/TET2 | 3 |
| GO:0072163 | Mesonephric epithelium development | 3/86 | 99/18866 | 0.010473779 | 0.105981576 | 0.085915831 | GATA3/SMAD6/BDNF | 3 |
| GO:0072164 | Mesonephric tubule development | 3/86 | 99/18866 | 0.010473779 | 0.105981576 | 0.085915831 | GATA3/SMAD6/BDNF | 3 |
| GO:0035510 | DNA dealkylation | 2/86 | 34/18866 | 0.010481928 | 0.105981576 | 0.085915831 | GATA3/TET2 | 2 |
| GO:0018205 | Peptidyl-lysine modification | 6/86 | 405/18866 | 0.010491465 | 0.105981576 | 0.085915831 | GATA3/RSF1/SOX4/ATP7A/HDAC9/TET2 | 6 |
| GO:0072001 | Renal system development | 5/86 | 292/18866 | 0.010791921 | 0.108556703 | 0.088003403 | GATA3/SMAD6/TGFB2/SOX4/BDNF | 5 |
| GO:0007369 | Gastrulation | 4/86 | 189/18866 | 0.010949043 | 0.108906117 | 0.088286661 | COL8A1/ITGAV/BMPR2/ITGB3 | 4 |
| GO:0007435 | Salivary gland morphogenesis | 2/86 | 35/18866 | 0.01108455 | 0.108906117 | 0.088286661 | TGFB2/SEMA3A | 2 |
| GO:0035909 | Aorta morphogenesis | 2/86 | 35/18866 | 0.01108455 | 0.108906117 | 0.088286661 | TGFB2/SOX4 | 2 |
| GO:0050779 | RNA destabilization | 2/86 | 35/18866 | 0.01108455 | 0.108906117 | 0.088286661 | CPEB3/CNOT6L | 2 |
| GO:0070306 | Lens fiber cell differentiation | 2/86 | 35/18866 | 0.01108455 | 0.108906117 | 0.088286661 | SLC7A11/SKIL | 2 |
| GO:0006575 | Cellular modified amino acid metabolic process | 4/86 | 190/18866 | 0.011146431 | 0.108906117 | 0.088286661 | SLC7A11/GATA3/MTHFR/CHAC1 | 4 |
| GO:0030308 | Negative regulation of cell growth | 4/86 | 190/18866 | 0.011146431 | 0.108906117 | 0.088286661 | TGFB2/SEMA3A/BMPR2/MAP2 | 4 |
| GO:0048167 | Regulation of synaptic plasticity | 4/86 | 191/18866 | 0.011346106 | 0.110036081 | 0.089202686 | CPEB3/PPP1R9A/SLC24A1/BDNF | 4 |
| GO:0110020 | Regulation of actomyosin structure organization | 3/86 | 102/18866 | 0.011354394 | 0.110036081 | 0.089202686 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0021953 | Central nervous system neuron differentiation | 4/86 | 192/18866 | 0.011548076 | 0.111010541 | 0.089992649 | SOX4/SEMA3A/ATP7A/MAP2 | 4 |
| GO:0044272 | Sulfur compound biosynthetic process | 4/86 | 192/18866 | 0.011548076 | 0.111010541 | 0.089992649 | SLC7A11/BCAN/MTHFR/CHAC1 | 4 |
| GO:0001823 | Mesonephros development | 3/86 | 103/18866 | 0.011657152 | 0.111591497 | 0.090463612 | GATA3/SMAD6/BDNF | 3 |
| GO:0071634 | Regulation of transforming growth factor beta production | 2/86 | 36/18866 | 0.011702128 | 0.111591497 | 0.090463612 | TGFB2/ITGAV | 2 |
| GO:0002793 | Positive regulation of peptide secretion | 4/86 | 193/18866 | 0.011752352 | 0.111623928 | 0.090489903 | SORL1/TGFB2/SOX4/MYO18A | 4 |
| GO:0010639 | Negative regulation of organelle organization | 6/86 | 416/18866 | 0.011857924 | 0.112179729 | 0.090940473 | PPP1R9A/CGNL1/USP30/TTBK2/ARHGAP28/MAP2 | 6 |
| GO:0032231 | Regulation of actin filament bundle assembly | 3/86 | 104/18866 | 0.011964538 | 0.112740945 | 0.091395432 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0048846 | Axon extension involved in axon guidance | 2/86 | 37/18866 | 0.012334518 | 0.11495818 | 0.093192873 | SEMA3A/BMPR2 | 2 |
| GO:1902284 | Neuron projection extension involved in neuron projection guidance | 2/86 | 37/18866 | 0.012334518 | 0.11495818 | 0.093192873 | SEMA3A/BMPR2 | 2 |
| GO:0050890 | Cognition | 5/86 | 302/18866 | 0.012344503 | 0.11495818 | 0.093192873 | CPEB3/SLC7A11/ATXN1/BDNF/PLCB1 | 5 |
| GO:0001841 | Neural tube formation | 3/86 | 106/18866 | 0.012593245 | 0.11502795 | 0.093249434 | TGFB2/SOX4/MTHFR | 3 |
| GO:0030038 | Contractile actin filament bundle assembly | 3/86 | 106/18866 | 0.012593245 | 0.11502795 | 0.093249434 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0032091 | Negative regulation of protein binding | 3/86 | 106/18866 | 0.012593245 | 0.11502795 | 0.093249434 | SORL1/TTBK2/MAP2 | 3 |
| GO:0034446 | Substrate adhesion-dependent cell spreading | 3/86 | 106/18866 | 0.012593245 | 0.11502795 | 0.093249434 | ITGAV/NEDD9/ITGB3 | 3 |
| GO:0043149 | Stress fiber assembly | 3/86 | 106/18866 | 0.012593245 | 0.11502795 | 0.093249434 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0051963 | Regulation of synapse assembly | 3/86 | 107/18866 | 0.012914585 | 0.116346145 | 0.094318051 | PPP1R9A/BDNF/SLITRK6 | 3 |
| GO:0007223 | Wnt signaling pathway, calcium modulating pathway | 2/86 | 38/18866 | 0.012981575 | 0.116346145 | 0.094318051 | PLCB1/TNRC6C | 2 |
| GO:0010742 | Macrophage derived foam cell differentiation | 2/86 | 38/18866 | 0.012981575 | 0.116346145 | 0.094318051 | ITGAV/ITGB3 | 2 |
| GO:0071604 | Transforming growth factor beta production | 2/86 | 38/18866 | 0.012981575 | 0.116346145 | 0.094318051 | TGFB2/ITGAV | 2 |
| GO:0090077 | Foam cell differentiation | 2/86 | 38/18866 | 0.012981575 | 0.116346145 | 0.094318051 | ITGAV/ITGB3 | 2 |
| GO:0007229 | Integrin-mediated signaling pathway | 3/86 | 108/18866 | 0.013240598 | 0.117782039 | 0.095482084 | ITGAV/NEDD9/ITGB3 | 3 |
| GO:0008593 | Regulation of Notch signaling pathway | 3/86 | 108/18866 | 0.013240598 | 0.117782039 | 0.095482084 | TGFB2/CHAC1/TP63 | 3 |
| GO:0001662 | Behavioral fear response | 2/86 | 39/18866 | 0.013643155 | 0.120019487 | 0.097295911 | FBXL20/BDNF | 2 |
| GO:0007431 | Salivary gland development | 2/86 | 39/18866 | 0.013643155 | 0.120019487 | 0.097295911 | TGFB2/SEMA3A | 2 |
| GO:0031111 | Negative regulation of microtubule polymerization or depolymerization | 2/86 | 39/18866 | 0.013643155 | 0.120019487 | 0.097295911 | TTBK2/MAP2 | 2 |
| GO:0090100 | Positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3/86 | 110/18866 | 0.013906677 | 0.121887936 | 0.098810602 | TGFB2/INHBB/BMPR2 | 3 |
| GO:0050808 | Synapse organization | 6/86 | 433/18866 | 0.01421063 | 0.122354017 | 0.099188438 | PPP1R9A/SLC7A11/GABRB3/BCAN/BDNF/SLITRK6 | 6 |
| GO:1903532 | Positive regulation of secretion by cell | 5/86 | 313/18866 | 0.014220651 | 0.122354017 | 0.099188438 | SORL1/TGFB2/SOX4/MYO18A/INHBB | 5 |
| GO:0000096 | Sulfur amino acid metabolic process | 2/86 | 40/18866 | 0.014319115 | 0.122354017 | 0.099188438 | SLC7A11/MTHFR | 2 |
| GO:0002209 | Behavioral defense response | 2/86 | 40/18866 | 0.014319115 | 0.122354017 | 0.099188438 | FBXL20/BDNF | 2 |
| GO:0010719 | Negative regulation of epithelial to mesenchymal transition | 2/86 | 40/18866 | 0.014319115 | 0.122354017 | 0.099188438 | GATA3/TGFB2 | 2 |
| GO:0042417 | Dopamine metabolic process | 2/86 | 40/18866 | 0.014319115 | 0.122354017 | 0.099188438 | TGFB2/ATP7A | 2 |
| GO:0043902 | Positive regulation of multi-organism process | 2/86 | 40/18866 | 0.014319115 | 0.122354017 | 0.099188438 | INHBB/PLCB1 | 2 |
| GO:0098656 | Anion transmembrane transport | 5/86 | 315/18866 | 0.014581278 | 0.123355537 | 0.100000338 | SLC7A11/CLIC4/SLC24A1/GABRB3/SLC38A2 | 5 |
| GO:0010927 | Cellular component assembly involved in morphogenesis | 3/86 | 112/18866 | 0.014591553 | 0.123355537 | 0.100000338 | NEBL/PGM5/ANK2 | 3 |
| GO:0099565 | Chemical synaptic transmission, postsynaptic | 3/86 | 112/18866 | 0.014591553 | 0.123355537 | 0.100000338 | PPP1R9A/GABRB3/BDNF | 3 |
| GO:0007009 | Plasma membrane organization | 3/86 | 113/18866 | 0.014941059 | 0.125112608 | 0.101424739 | TGFB2/ANK2/PACSIN1 | 3 |
| GO:0042596 | Fear response | 2/86 | 41/18866 | 0.015009315 | 0.125112608 | 0.101424739 | FBXL20/BDNF | 2 |
| GO:0050434 | Positive regulation of viral transcription | 2/86 | 41/18866 | 0.015009315 | 0.125112608 | 0.101424739 | CCNT1/RSF1 | 2 |
| GO:2000826 | Regulation of heart morphogenesis | 2/86 | 41/18866 | 0.015009315 | 0.125112608 | 0.101424739 | TGFB2/BMPR2 | 2 |
| GO:0043200 | Response to amino acid | 3/86 | 114/18866 | 0.015295288 | 0.127052153 | 0.102997065 | CPEB3/MTHFR/ATP7A | 3 |
| GO:0043393 | Regulation of protein binding | 4/86 | 211/18866 | 0.015833518 | 0.13061283 | 0.105883591 | SORL1/BDNF/TTBK2/MAP2 | 4 |
| GO:0050679 | Positive regulation of epithelial cell proliferation | 4/86 | 211/18866 | 0.015833518 | 0.13061283 | 0.105883591 | ATP7A/BMPR2/ITGB3/TP63 | 4 |
| GO:0030278 | Regulation of ossification | 4/86 | 212/18866 | 0.016083232 | 0.131760911 | 0.106814303 | SMAD6/TGFB2/BMPR2/TP63 | 4 |
| GO:1901215 | Negative regulation of neuron death | 4/86 | 212/18866 | 0.016083232 | 0.131760911 | 0.106814303 | SORL1/SLC7A11/GABRB3/BDNF | 4 |
| GO:0030517 | Negative regulation of axon extension | 2/86 | 43/18866 | 0.016431868 | 0.133243447 | 0.108016147 | SEMA3A/MAP2 | 2 |
| GO:0040019 | Positive regulation of embryonic development | 2/86 | 43/18866 | 0.016431868 | 0.133243447 | 0.108016147 | GATA3/PLCB1 | 2 |
| GO:0060119 | Inner ear receptor cell development | 2/86 | 43/18866 | 0.016431868 | 0.133243447 | 0.108016147 | GABRB3/SLITRK6 | 2 |
| GO:0043523 | Regulation of neuron apoptotic process | 4/86 | 214/18866 | 0.016590079 | 0.134070337 | 0.108686479 | GATA3/GABRB3/TGFB2/BDNF | 4 |
| GO:0071496 | Cellular response to external stimulus | 5/86 | 326/18866 | 0.016675122 | 0.134302338 | 0.108874555 | NUAK1/SLC38A2/GABARAPL1/INHBB/BMPR2 | 5 |
| GO:0046660 | Female sex differentiation | 3/86 | 119/18866 | 0.017137505 | 0.135942997 | 0.110204584 | FST/INHBB/TP63 | 3 |
| GO:0045684 | Positive regulation of epidermis development | 2/86 | 44/18866 | 0.017163944 | 0.135942997 | 0.110204584 | FST/TGFB2 | 2 |
| GO:0060999 | Positive regulation of dendritic spine development | 2/86 | 44/18866 | 0.017163944 | 0.135942997 | 0.110204584 | CPEB3/PPP1R9A | 2 |
| GO:1901985 | Positive regulation of protein acetylation | 2/86 | 44/18866 | 0.017163944 | 0.135942997 | 0.110204584 | GATA3/SOX4 | 2 |
| GO:1902667 | Regulation of axon guidance | 2/86 | 44/18866 | 0.017163944 | 0.135942997 | 0.110204584 | SEMA3A/BMPR2 | 2 |
| GO:0006304 | DNA modification | 3/86 | 120/18866 | 0.017520203 | 0.137848726 | 0.111749497 | GATA3/ATF7IP/TET2 | 3 |
| GO:0051588 | Regulation of neurotransmitter transport | 3/86 | 120/18866 | 0.017520203 | 0.137848726 | 0.111749497 | PPP1R9A/FBXL20/ITGB3 | 3 |
| GO:0006338 | Chromatin remodeling | 4/86 | 218/18866 | 0.017633653 | 0.138177114 | 0.11201571 | GATA3/RSF1/ATF7IP/TP63 | 4 |
| GO:0060562 | Epithelial tube morphogenesis | 5/86 | 331/18866 | 0.017689868 | 0.138177114 | 0.11201571 | GATA3/CLIC4/TGFB2/SOX4/MTHFR | 5 |
| GO:0002065 | Columnar/cuboidal epithelial cell differentiation | 3/86 | 121/18866 | 0.017907664 | 0.138177114 | 0.11201571 | SOX4/SLITRK6/TP63 | 3 |
| GO:0001974 | Blood vessel remodeling | 2/86 | 45/18866 | 0.017909701 | 0.138177114 | 0.11201571 | ATP7A/BMPR2 | 2 |
| GO:0003197 | Endocardial cushion development | 2/86 | 45/18866 | 0.017909701 | 0.138177114 | 0.11201571 | TGFB2/BMPR2 | 2 |
| GO:0014047 | Glutamate secretion | 2/86 | 45/18866 | 0.017909701 | 0.138177114 | 0.11201571 | BDNF/SLC38A2 | 2 |
| GO:0007163 | Establishment or maintenance of cell polarity | 4/86 | 220/18866 | 0.01817049 | 0.139736926 | 0.1132802 | GATA3/CLIC4/MYO18A/MAP2 | 4 |
| GO:0097237 | Cellular response to toxic substance | 3/86 | 122/18866 | 0.018299893 | 0.140279566 | 0.1137201 | PPP1R9A/ATP7A/TP53INP1 | 3 |
| GO:0032570 | Response to progesterone | 2/86 | 46/18866 | 0.018669004 | 0.142194587 | 0.115272545 | NCOA2/TGFB2 | 2 |
| GO:0035987 | Endodermal cell differentiation | 2/86 | 46/18866 | 0.018669004 | 0.142194587 | 0.115272545 | COL8A1/ITGAV | 2 |
| GO:0009306 | Protein secretion | 6/86 | 462/18866 | 0.018947479 | 0.143856018 | 0.116619414 | SORL1/TGFB2/SOX4/HDAC9/MYO18A/INHBB | 6 |
| GO:0022612 | Gland morphogenesis | 3/86 | 124/18866 | 0.019098668 | 0.144306981 | 0.116984995 | TGFB2/SEMA3A/TP63 | 3 |
| GO:0035592 | Establishment of protein localization to extracellular region | 6/86 | 463/18866 | 0.019127939 | 0.144306981 | 0.116984995 | SORL1/TGFB2/SOX4/HDAC9/MYO18A/INHBB | 6 |
| GO:0006378 | mRNA polyadenylation | 2/86 | 47/18866 | 0.019441716 | 0.144389565 | 0.117051943 | CPEB3/CCNT1 | 2 |
| GO:0032369 | Negative regulation of lipid transport | 2/86 | 47/18866 | 0.019441716 | 0.144389565 | 0.117051943 | ITGAV/ITGB3 | 2 |
| GO:0060986 | Endocrine hormone secretion | 2/86 | 47/18866 | 0.019441716 | 0.144389565 | 0.117051943 | GATA3/INHBB | 2 |
| GO:1904738 | Vascular associated smooth muscle cell migration | 2/86 | 47/18866 | 0.019441716 | 0.144389565 | 0.117051943 | ATP7A/PRKG1 | 2 |
| GO:1904752 | Regulation of vascular associated smooth muscle cell migration | 2/86 | 47/18866 | 0.019441716 | 0.144389565 | 0.117051943 | ATP7A/PRKG1 | 2 |
| GO:0016570 | Histone modification | 6/86 | 468/18866 | 0.02004796 | 0.148094346 | 0.120055289 | GATA3/RSF1/MTHFR/HDAC9/TET2/JMJD1C | 6 |
| GO:0009101 | Glycoprotein biosynthetic process | 5/86 | 342/18866 | 0.020064796 | 0.148094346 | 0.120055289 | BCAN/ATP7A/BMPR2/PLCB1/TET2 | 5 |
| GO:0043631 | RNA polyadenylation | 2/86 | 48/18866 | 0.020227701 | 0.148835926 | 0.120656465 | CPEB3/CCNT1 | 2 |
| GO:0007596 | Blood coagulation | 5/86 | 343/18866 | 0.020290572 | 0.14883915 | 0.120659078 | SLC7A11/GATA3/PRKG1/JMJD1C/ITGB3 | 5 |
| GO:0071692 | Protein localization to extracellular region | 6/86 | 470/18866 | 0.0204243 | 0.149360526 | 0.12108174 | SORL1/TGFB2/SOX4/HDAC9/MYO18A/INHBB | 6 |
| GO:1903311 | Regulation of mRNA metabolic process | 5/86 | 344/18866 | 0.020518013 | 0.149586983 | 0.121265322 | CPEB3/CCNT1/MBNL2/TNRC6C/CNOT6L | 5 |
| GO:0050807 | Regulation of synapse organization | 4/86 | 229/18866 | 0.020712003 | 0.150540902 | 0.122038633 | PPP1R9A/SLC7A11/BDNF/SLITRK6 | 4 |
| GO:0015695 | Organic cation transport | 2/86 | 49/18866 | 0.021026827 | 0.151902896 | 0.123142758 | SLC38A2/ITGB3 | 2 |
| GO:0042398 | Cellular modified amino acid biosynthetic process | 2/86 | 49/18866 | 0.021026827 | 0.151902896 | 0.123142758 | SLC7A11/CHAC1 | 2 |
| GO:0032271 | Regulation of protein polymerization | 4/86 | 231/18866 | 0.021305014 | 0.153447596 | 0.124394996 | PPP1R9A/ARHGAP28/JMY/MAP2 | 4 |
| GO:0007599 | Hemostasis | 5/86 | 348/18866 | 0.021444515 | 0.153987119 | 0.12483237 | SLC7A11/GATA3/PRKG1/JMJD1C/ITGB3 | 5 |
| GO:0050817 | Coagulation | 5/86 | 349/18866 | 0.021680346 | 0.154492818 | 0.125242323 | SLC7A11/GATA3/PRKG1/JMJD1C/ITGB3 | 5 |
| GO:0008544 | Epidermis development | 6/86 | 477/18866 | 0.02177946 | 0.154492818 | 0.125242323 | FST/CLIC4/TGFB2/ATP7A/SLITRK6/TP63 | 6 |
| GO:0008038 | Neuron recognition | 2/86 | 50/18866 | 0.02183896 | 0.154492818 | 0.125242323 | BDNF/SEMA3A | 2 |
| GO:0021695 | Cerebellar cortex development | 2/86 | 50/18866 | 0.02183896 | 0.154492818 | 0.125242323 | ATP7A/TTBK2 | 2 |
| GO:0043616 | Keratinocyte proliferation | 2/86 | 50/18866 | 0.02183896 | 0.154492818 | 0.125242323 | FST/TP63 | 2 |
| GO:0030336 | Negative regulation of cell migration | 5/86 | 350/18866 | 0.021917868 | 0.1545923 | 0.12532297 | CLIC4/SEMA3A/PLCB1/PRKG1/TP53INP1 | 5 |
| GO:0045667 | Regulation of osteoblast differentiation | 3/86 | 131/18866 | 0.022045008 | 0.155030383 | 0.12567811 | SMAD6/BMPR2/TP63 | 3 |
| GO:0001101 | Response to acid chemical | 3/86 | 132/18866 | 0.022485065 | 0.155708635 | 0.126227947 | CPEB3/MTHFR/ATP7A | 3 |
| GO:0042476 | Odontogenesis | 3/86 | 132/18866 | 0.022485065 | 0.155708635 | 0.126227947 | FST/TGFB2/TP63 | 3 |
| GO:0045444 | Fat cell differentiation | 4/86 | 235/18866 | 0.022522167 | 0.155708635 | 0.126227947 | GATA3/SMAD6/INHBB/PLCB1 | 4 |
| GO:0048638 | Regulation of developmental growth | 5/86 | 353/18866 | 0.022640619 | 0.155708635 | 0.126227947 | BDNF/SEMA3A/BMPR2/PLCB1/MAP2 | 5 |
| GO:0021545 | Cranial nerve development | 2/86 | 51/18866 | 0.022663967 | 0.155708635 | 0.126227947 | SEMA3A/SLITRK6 | 2 |
| GO:0021879 | Forebrain neuron differentiation | 2/86 | 51/18866 | 0.022663967 | 0.155708635 | 0.126227947 | SEMA3A/ATP7A | 2 |
| GO:0035272 | Exocrine system development | 2/86 | 51/18866 | 0.022663967 | 0.155708635 | 0.126227947 | TGFB2/SEMA3A | 2 |
| GO:0043277 | Apoptotic cell clearance | 2/86 | 51/18866 | 0.022663967 | 0.155708635 | 0.126227947 | ITGAV/ITGB3 | 2 |
| GO:0060560 | Developmental growth involved in morphogenesis | 4/86 | 236/18866 | 0.022832971 | 0.156325812 | 0.126728272 | BDNF/SEMA3A/BMPR2/MAP2 | 4 |
| GO:0051222 | Positive regulation of protein transport | 5/86 | 354/18866 | 0.022884945 | 0.156325812 | 0.126728272 | SORL1/TGFB2/SOX4/MYO18A/TP63 | 5 |
| GO:0032872 | Regulation of stress-activated MAPK cascade | 4/86 | 237/18866 | 0.023146391 | 0.157210815 | 0.127445716 | SASH1/TGFB2/SEMA3A/PLCB1 | 4 |
| GO:0048588 | Developmental cell growth | 4/86 | 237/18866 | 0.023146391 | 0.157210815 | 0.127445716 | BDNF/SEMA3A/BMPR2/MAP2 | 4 |
| GO:0007498 | Mesoderm development | 3/86 | 134/18866 | 0.023379551 | 0.158271449 | 0.128305537 | BMPR2/ITGB3/TP63 | 3 |
| GO:0034249 | Negative regulation of cellular amide metabolic process | 4/86 | 238/18866 | 0.023462432 | 0.158271449 | 0.128305537 | SORL1/CPEB3/TNRC6C/CNOT6L | 4 |
| GO:0010883 | Regulation of lipid storage | 2/86 | 52/18866 | 0.023501717 | 0.158271449 | 0.128305537 | ITGAV/ITGB3 | 2 |
| GO:0050803 | Regulation of synapse structure or activity | 4/86 | 240/18866 | 0.024102395 | 0.161152503 | 0.130641115 | PPP1R9A/SLC7A11/BDNF/SLITRK6 | 4 |
| GO:0070302 | Regulation of stress-activated protein kinase signaling cascade | 4/86 | 240/18866 | 0.024102395 | 0.161152503 | 0.130641115 | SASH1/TGFB2/SEMA3A/PLCB1 | 4 |
| GO:0031589 | Cell-substrate adhesion | 5/86 | 359/18866 | 0.024132317 | 0.161152503 | 0.130641115 | COL8A1/SMAD6/ITGAV/NEDD9/ITGB3 | 5 |
| GO:0042073 | Intraciliary transport | 2/86 | 53/18866 | 0.02435208 | 0.162165805 | 0.131462566 | RABL2B/LCA5 | 2 |
| GO:0006749 | Glutathione metabolic process | 2/86 | 54/18866 | 0.025214926 | 0.167052167 | 0.135423781 | SLC7A11/CHAC1 | 2 |
| GO:0046330 | Positive regulation of JNK cascade | 3/86 | 138/18866 | 0.025225998 | 0.167052167 | 0.135423781 | SASH1/SEMA3A/PLCB1 | 3 |
| GO:0001706 | Endoderm formation | 2/86 | 55/18866 | 0.026090127 | 0.171820063 | 0.139288959 | COL8A1/ITGAV | 2 |
| GO:0030199 | Collagen fibril organization | 2/86 | 55/18866 | 0.026090127 | 0.171820063 | 0.139288959 | TGFB2/ATP7A | 2 |
| GO:0008584 | Male gonad development | 3/86 | 141/18866 | 0.026661088 | 0.174456189 | 0.141425982 | GATA3/TGFB2/SEMA3A | 3 |
| GO:0030010 | Establishment of cell polarity | 3/86 | 141/18866 | 0.026661088 | 0.174456189 | 0.141425982 | GATA3/MYO18A/MAP2 | 3 |
| GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2/86 | 56/18866 | 0.026977555 | 0.174456189 | 0.141425982 | SOX4/CNOT6L | 2 |
| GO:0044273 | Sulfur compound catabolic process | 2/86 | 56/18866 | 0.026977555 | 0.174456189 | 0.141425982 | BCAN/CHAC1 | 2 |
| GO:0060563 | Neuroepithelial cell differentiation | 2/86 | 56/18866 | 0.026977555 | 0.174456189 | 0.141425982 | SOX4/SLITRK6 | 2 |
| GO:1904951 | Positive regulation of establishment of protein localization | 5/86 | 370/18866 | 0.027029446 | 0.174456189 | 0.141425982 | SORL1/TGFB2/SOX4/MYO18A/TP63 | 5 |
| GO:0031333 | Negative regulation of protein-containing complex assembly | 3/86 | 142/18866 | 0.027149013 | 0.174456189 | 0.141425982 | SORL1/SMAD6/MAP2 | 3 |
| GO:0046546 | Development of primary male sexual characteristics | 3/86 | 142/18866 | 0.027149013 | 0.174456189 | 0.141425982 | GATA3/TGFB2/SEMA3A | 3 |
| GO:0072073 | Kidney epithelium development | 3/86 | 142/18866 | 0.027149013 | 0.174456189 | 0.141425982 | GATA3/SMAD6/BDNF | 3 |
| GO:0016571 | Histone methylation | 3/86 | 143/18866 | 0.027641714 | 0.176752565 | 0.143287579 | GATA3/MTHFR/TET2 | 3 |
| GO:0045747 | Positive regulation of Notch signaling pathway | 2/86 | 57/18866 | 0.027877082 | 0.176752565 | 0.143287579 | TGFB2/TP63 | 2 |
| GO:0051568 | Histone H3-K4 methylation | 2/86 | 57/18866 | 0.027877082 | 0.176752565 | 0.143287579 | GATA3/TET2 | 2 |
| GO:0072431 | Signal transduction involved in mitotic G1 DNA damage checkpoint | 2/86 | 57/18866 | 0.027877082 | 0.176752565 | 0.143287579 | SOX4/CNOT6L | 2 |
| GO:1902400 | Intracellular signal transduction involved in G1 DNA damage checkpoint | 2/86 | 57/18866 | 0.027877082 | 0.176752565 | 0.143287579 | SOX4/CNOT6L | 2 |
| GO:0060078 | Regulation of postsynaptic membrane potential | 3/86 | 144/18866 | 0.028139189 | 0.177941187 | 0.144251156 | PPP1R9A/GABRB3/BDNF | 3 |
| GO:0045926 | Negative regulation of growth | 4/86 | 254/18866 | 0.02887904 | 0.181656023 | 0.147262653 | TGFB2/SEMA3A/BMPR2/MAP2 | 4 |
| GO:2000027 | Regulation of animal organ morphogenesis | 4/86 | 254/18866 | 0.02887904 | 0.181656023 | 0.147262653 | GATA3/TGFB2/BDNF/BMPR2 | 4 |
| GO:0048813 | Dendrite morphogenesis | 3/86 | 146/18866 | 0.029148446 | 0.182868148 | 0.148245284 | PPP1R9A/SEMA3A/MAP2 | 3 |
| GO:0050707 | Regulation of cytokine secretion | 2/86 | 59/18866 | 0.029711935 | 0.183505836 | 0.148762237 | SORL1/HDAC9 | 2 |
| GO:0051058 | Negative regulation of small GTPase mediated signal transduction | 2/86 | 59/18866 | 0.029711935 | 0.183505836 | 0.148762237 | CGNL1/TGFB2 | 2 |
| GO:0060113 | Inner ear receptor cell differentiation | 2/86 | 59/18866 | 0.029711935 | 0.183505836 | 0.148762237 | GABRB3/SLITRK6 | 2 |
| GO:0072413 | Signal transduction involved in mitotic cell cycle checkpoint | 2/86 | 59/18866 | 0.029711935 | 0.183505836 | 0.148762237 | SOX4/CNOT6L | 2 |
| GO:1902402 | Signal transduction involved in mitotic DNA damage checkpoint | 2/86 | 59/18866 | 0.029711935 | 0.183505836 | 0.148762237 | SOX4/CNOT6L | 2 |
| GO:1902403 | Signal transduction involved in mitotic DNA integrity checkpoint | 2/86 | 59/18866 | 0.029711935 | 0.183505836 | 0.148762237 | SOX4/CNOT6L | 2 |
| GO:0042093 | T-helper cell differentiation | 2/86 | 60/18866 | 0.03064701 | 0.187339672 | 0.151870204 | GATA3/ATP7A | 2 |
| GO:0048747 | Muscle fiber development | 2/86 | 60/18866 | 0.03064701 | 0.187339672 | 0.151870204 | NEBL/HDAC9 | 2 |
| GO:0061098 | Positive regulation of protein tyrosine kinase activity | 2/86 | 60/18866 | 0.03064701 | 0.187339672 | 0.151870204 | BDNF/NEDD9 | 2 |
| GO:0097755 | Positive regulation of blood vessel diameter | 2/86 | 60/18866 | 0.03064701 | 0.187339672 | 0.151870204 | BMPR2/PRKG1 | 2 |
| GO:0035107 | Appendage morphogenesis | 3/86 | 150/18866 | 0.031224077 | 0.189410176 | 0.153548695 | TGFB2/SOX4/TP63 | 3 |
| GO:0035108 | Limb morphogenesis | 3/86 | 150/18866 | 0.031224077 | 0.189410176 | 0.153548695 | TGFB2/SOX4/TP63 | 3 |
| GO:0060041 | Retina development in camera-type eye | 3/86 | 150/18866 | 0.031224077 | 0.189410176 | 0.153548695 | CLIC4/TGFB2/BMPR2 | 3 |
| GO:0021872 | Forebrain generation of neurons | 2/86 | 61/18866 | 0.031593687 | 0.190681897 | 0.154579637 | SEMA3A/ATP7A | 2 |
| GO:2000756 | Regulation of peptidyl-lysine acetylation | 2/86 | 61/18866 | 0.031593687 | 0.190681897 | 0.154579637 | GATA3/SOX4 | 2 |
| GO:0050684 | Regulation of mRNA processing | 3/86 | 152/18866 | 0.032290377 | 0.194394591 | 0.157589398 | CPEB3/CCNT1/MBNL2 | 3 |
| GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 2/86 | 62/18866 | 0.032551842 | 0.194858921 | 0.157965815 | GATA3/ATP7A | 2 |
| GO:0034113 | Heterotypic cell-cell adhesion | 2/86 | 62/18866 | 0.032551842 | 0.194858921 | 0.157965815 | ITGAV/ITGB3 | 2 |
| GO:0048863 | Stem cell differentiation | 4/86 | 264/18866 | 0.032612714 | 0.194858921 | 0.157965815 | GATA3/TGFB2/SEMA3A/TP63 | 4 |
| GO:0042692 | Muscle cell differentiation | 5/86 | 390/18866 | 0.032848287 | 0.195775793 | 0.158709094 | NEBL/PGM5/BDNF/HDAC9/ANK2 | 5 |
| GO:0002287 | Alpha-beta T cell activation involved in immune response | 2/86 | 63/18866 | 0.033521355 | 0.197809181 | 0.160357496 | GATA3/ATP7A | 2 |
| GO:0002293 | Alpha-beta T cell differentiation involved in immune response | 2/86 | 63/18866 | 0.033521355 | 0.197809181 | 0.160357496 | GATA3/ATP7A | 2 |
| GO:0010830 | Regulation of myotube differentiation | 2/86 | 63/18866 | 0.033521355 | 0.197809181 | 0.160357496 | BDNF/HDAC9 | 2 |
| GO:0031571 | Mitotic G1 DNA damage checkpoint | 2/86 | 63/18866 | 0.033521355 | 0.197809181 | 0.160357496 | SOX4/CNOT6L | 2 |
| GO:0050773 | Regulation of dendrite development | 3/86 | 155/18866 | 0.033925312 | 0.199698629 | 0.16188921 | CPEB3/PPP1R9A/PACSIN1 | 3 |
| GO:0006865 | Amino acid transport | 3/86 | 156/18866 | 0.03447973 | 0.200587288 | 0.162609617 | SLC7A11/BDNF/SLC38A2 | 3 |
| GO:0043484 | Regulation of RNA splicing | 3/86 | 156/18866 | 0.03447973 | 0.200587288 | 0.162609617 | MBNL2/SLC38A2/AHNAK2 | 3 |
| GO:0030166 | Proteoglycan biosynthetic process | 2/86 | 64/18866 | 0.034502103 | 0.200587288 | 0.162609617 | BCAN/BMPR2 | 2 |
| GO:0044783 | G1 DNA damage checkpoint | 2/86 | 64/18866 | 0.034502103 | 0.200587288 | 0.162609617 | SOX4/CNOT6L | 2 |
| GO:0044819 | Mitotic G1/S transition checkpoint | 2/86 | 64/18866 | 0.034502103 | 0.200587288 | 0.162609617 | SOX4/CNOT6L | 2 |
| GO:0090596 | Sensory organ morphogenesis | 4/86 | 269/18866 | 0.034581114 | 0.200587288 | 0.162609617 | COL8A1/GATA3/BDNF/SLITRK6 | 4 |
| GO:0045787 | Positive regulation of cell cycle | 5/86 | 396/18866 | 0.034735534 | 0.200993965 | 0.162939297 | CCNT1/TGFB2/SOX4/PLCB1/CNOT6L | 5 |
| GO:0046782 | Regulation of viral transcription | 2/86 | 65/18866 | 0.035493968 | 0.204390387 | 0.165692666 | CCNT1/RSF1 | 2 |
| GO:1905953 | Negative regulation of lipid localization | 2/86 | 65/18866 | 0.035493968 | 0.204390387 | 0.165692666 | ITGAV/ITGB3 | 2 |
| GO:0030168 | Platelet activation | 3/86 | 158/18866 | 0.035602685 | 0.20452241 | 0.165799693 | SLC7A11/PRKG1/ITGB3 | 3 |
| GO:0032922 | Circadian regulation of gene expression | 2/86 | 66/18866 | 0.03649683 | 0.208154171 | 0.168743844 | AHR/NCOA2 | 2 |
| GO:0034394 | Protein localization to cell surface | 2/86 | 66/18866 | 0.03649683 | 0.208154171 | 0.168743844 | BDNF/ANK2 | 2 |
| GO:0045669 | Positive regulation of osteoblast differentiation | 2/86 | 66/18866 | 0.03649683 | 0.208154171 | 0.168743844 | BMPR2/TP63 | 2 |
| GO:0045927 | Positive regulation of growth | 4/86 | 274/18866 | 0.03661755 | 0.208344248 | 0.168897933 | TGFB2/BDNF/BMPR2/PLCB1 | 4 |
| GO:0010970 | Transport along microtubule | 3/86 | 161/18866 | 0.037322311 | 0.211407097 | 0.171380886 | RABL2B/LCA5/MAP2 | 3 |
| GO:0030239 | Myofibril assembly | 2/86 | 67/18866 | 0.037510571 | 0.211407097 | 0.171380886 | NEBL/PGM5 | 2 |
| GO:0031060 | Regulation of histone methylation | 2/86 | 67/18866 | 0.037510571 | 0.211407097 | 0.171380886 | GATA3/MTHFR | 2 |
| GO:0051965 | Positive regulation of synapse assembly | 2/86 | 67/18866 | 0.037510571 | 0.211407097 | 0.171380886 | BDNF/SLITRK6 | 2 |
| GO:0032970 | Regulation of actin filament-based process | 5/86 | 405/18866 | 0.037690922 | 0.211922541 | 0.17179874 | PPP1R9A/CGNL1/ARHGAP28/ANK2/JMY | 5 |
| GO:0110053 | Regulation of actin filament organization | 4/86 | 278/18866 | 0.038295803 | 0.213645618 | 0.173195582 | PPP1R9A/CGNL1/ARHGAP28/JMY | 4 |
| GO:0021915 | Neural tube development | 3/86 | 163/18866 | 0.038492103 | 0.213645618 | 0.173195582 | TGFB2/SOX4/MTHFR | 3 |
| GO:0072577 | Endothelial cell apoptotic process | 2/86 | 68/18866 | 0.038535074 | 0.213645618 | 0.173195582 | GATA3/BMPR2 | 2 |
| GO:0098840 | Protein transport along microtubule | 2/86 | 68/18866 | 0.038535074 | 0.213645618 | 0.173195582 | RABL2B/LCA5 | 2 |
| GO:0099118 | Microtubule-based protein transport | 2/86 | 68/18866 | 0.038535074 | 0.213645618 | 0.173195582 | RABL2B/LCA5 | 2 |
| GO:1904888 | Cranial skeletal system development | 2/86 | 68/18866 | 0.038535074 | 0.213645618 | 0.173195582 | TGFB2/TP63 | 2 |
| GO:0001764 | Neuron migration | 3/86 | 164/18866 | 0.039083988 | 0.215208675 | 0.174462702 | GATA3/SEMA3A/PRKG1 | 3 |
| GO:0046661 | Male sex differentiation | 3/86 | 164/18866 | 0.039083988 | 0.215208675 | 0.174462702 | GATA3/TGFB2/SEMA3A | 3 |
| GO:0071230 | Cellular response to amino acid stimulus | 2/86 | 69/18866 | 0.039570221 | 0.215208675 | 0.174462702 | CPEB3/ATP7A | 2 |
| GO:1903317 | Regulation of protein maturation | 2/86 | 69/18866 | 0.039570221 | 0.215208675 | 0.174462702 | SOX4/CHAC1 | 2 |
| GO:1903531 | Negative regulation of secretion by cell | 3/86 | 166/18866 | 0.040281693 | 0.215208675 | 0.174462702 | PPP1R9A/HDAC9/INHBB | 3 |
| GO:2001233 | Regulation of apoptotic signaling pathway | 5/86 | 413/18866 | 0.040444458 | 0.215208675 | 0.174462702 | SKIL/BDNF/ITGAV/INHBB/TP63 | 5 |
| GO:0009880 | Embryonic pattern specification | 2/86 | 70/18866 | 0.040615897 | 0.215208675 | 0.174462702 | SMAD6/SEMA3A | 2 |
| GO:0050771 | Negative regulation of axonogenesis | 2/86 | 70/18866 | 0.040615897 | 0.215208675 | 0.174462702 | SEMA3A/MAP2 | 2 |
| GO:0009100 | Glycoprotein metabolic process | 5/86 | 415/18866 | 0.041151564 | 0.215208675 | 0.174462702 | BCAN/ATP7A/BMPR2/PLCB1/TET2 | 5 |
| GO:0002292 | T cell differentiation involved in immune response | 2/86 | 71/18866 | 0.041671986 | 0.215208675 | 0.174462702 | GATA3/ATP7A | 2 |
| GO:0051403 | Stress-activated MAPK cascade | 4/86 | 286/18866 | 0.041783498 | 0.215208675 | 0.174462702 | SASH1/TGFB2/SEMA3A/PLCB1 | 4 |
| GO:0055002 | Striated muscle cell development | 3/86 | 169/18866 | 0.042112957 | 0.215208675 | 0.174462702 | NEBL/PGM5/HDAC9 | 3 |
| GO:2000241 | Regulation of reproductive process | 3/86 | 170/18866 | 0.042732596 | 0.215208675 | 0.174462702 | SEMA3A/INHBB/PLCB1 | 3 |
| GO:0050663 | Cytokine secretion | 2/86 | 72/18866 | 0.042738376 | 0.215208675 | 0.174462702 | SORL1/HDAC9 | 2 |
| GO:0001558 | Regulation of cell growth | 5/86 | 420/18866 | 0.042952231 | 0.215208675 | 0.174462702 | TGFB2/BDNF/SEMA3A/BMPR2/MAP2 | 5 |
| GO:0030307 | Positive regulation of cell growth | 3/86 | 171/18866 | 0.043356828 | 0.215208675 | 0.174462702 | TGFB2/BDNF/BMPR2 | 3 |
| GO:0060485 | Mesenchyme development | 4/86 | 290/18866 | 0.043592995 | 0.215208675 | 0.174462702 | GATA3/TGFB2/SEMA3A/BMPR2 | 4 |
| GO:0097193 | Intrinsic apoptotic signaling pathway | 4/86 | 290/18866 | 0.043592995 | 0.215208675 | 0.174462702 | SKIL/CHAC1/JMY/TP63 | 4 |
| GO:0015807 | l-amino acid transport | 2/86 | 73/18866 | 0.043814951 | 0.215208675 | 0.174462702 | SLC7A11/SLC38A2 | 2 |
| GO:0072401 | Signal transduction involved in DNA integrity checkpoint | 2/86 | 73/18866 | 0.043814951 | 0.215208675 | 0.174462702 | SOX4/CNOT6L | 2 |
| GO:0072422 | Signal transduction involved in DNA damage checkpoint | 2/86 | 73/18866 | 0.043814951 | 0.215208675 | 0.174462702 | SOX4/CNOT6L | 2 |
| GO:0002244 | Hematopoietic progenitor cell differentiation | 3/86 | 172/18866 | 0.043985644 | 0.215208675 | 0.174462702 | FST/GATA3/SOX4 | 3 |
| GO:0018394 | Peptidyl-lysine acetylation | 3/86 | 172/18866 | 0.043985644 | 0.215208675 | 0.174462702 | GATA3/RSF1/SOX4 | 3 |
| GO:0021543 | Pallium development | 3/86 | 173/18866 | 0.044619032 | 0.215208675 | 0.174462702 | BCAN/SLC38A2/PLCB1 | 3 |
| GO:0002524 | Hypersensitivity | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:0003149 | Membranous septum morphogenesis | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | TGFB2 | 1 |
| GO:0003211 | Cardiac ventricle formation | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | SOX4 | 1 |
| GO:0010603 | Regulation of cytoplasmic mRNA processing body assembly | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | CNOT6L | 1 |
| GO:0021562 | Vestibulocochlear nerve development | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | SLITRK6 | 1 |
| GO:0021859 | Pyramidal neuron differentiation | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0032025 | Response to cobalt ion | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0032926 | Negative regulation of activin receptor signaling pathway | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | FST | 1 |
| GO:0035860 | Glial cell-derived neurotrophic factor receptor signaling pathway | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:0035871 | Protein K11-linked deubiquitination | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | USP30 | 1 |
| GO:0035999 | Tetrahydrofolate interconversion | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | MTHFR | 1 |
| GO:0042428 | Serotonin metabolic process | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0044557 | Relaxation of smooth muscle | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | PRKG1 | 1 |
| GO:0045793 | Positive regulation of cell size | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0048251 | Elastic fiber assembly | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0051541 | Elastin metabolic process | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0060513 | Prostatic bud formation | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | TP63 | 1 |
| GO:0060600 | Dichotomous subdivision of an epithelial terminal unit | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | SEMA3A | 1 |
| GO:0086070 | SA node cell to atrial cardiac muscle cell communication | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ANK2 | 1 |
| GO:0090527 | Actin filament reorganization | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | NEDD9 | 1 |
| GO:1902946 | Protein localization to early endosome | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | SORL1 | 1 |
| GO:1904672 | Regulation of somatic stem cell population maintenance | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | TP63 | 1 |
| GO:1904684 | Negative regulation of metalloendopeptidase activity | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | SORL1 | 1 |
| GO:2000018 | Regulation of male gonad development | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | SEMA3A | 1 |
| GO:2000271 | Positive regulation of fibroblast apoptotic process | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | TP63 | 1 |
| GO:0043588 | Skin development | 5/86 | 425/18866 | 0.044800039 | 0.215208675 | 0.174462702 | FST/CLIC4/TGFB2/ATP7A/TP63 | 5 |
| GO:0072395 | Signal transduction involved in cell cycle checkpoint | 2/86 | 74/18866 | 0.0449016 | 0.215208675 | 0.174462702 | SOX4/CNOT6L | 2 |
| GO:0030833 | Regulation of actin filament polymerization | 3/86 | 174/18866 | 0.045256984 | 0.215208675 | 0.174462702 | PPP1R9A/ARHGAP28/JMY | 3 |
| GO:0010921 | Regulation of phosphatase activity | 3/86 | 175/18866 | 0.045899487 | 0.215208675 | 0.174462702 | NUAK1/SYTL2/TGFB2 | 3 |
| GO:0050768 | Negative regulation of neurogenesis | 4/86 | 295/18866 | 0.045916409 | 0.215208675 | 0.174462702 | SORL1/BDNF/SEMA3A/MAP2 | 4 |
| GO:0051146 | Striated muscle cell differentiation | 4/86 | 295/18866 | 0.045916409 | 0.215208675 | 0.174462702 | NEBL/PGM5/BDNF/HDAC9 | 4 |
| GO:0001707 | Mesoderm formation | 2/86 | 75/18866 | 0.045998211 | 0.215208675 | 0.174462702 | BMPR2/ITGB3 | 2 |
| GO:0035019 | Somatic stem cell population maintenance | 2/86 | 75/18866 | 0.045998211 | 0.215208675 | 0.174462702 | SOX4/TP63 | 2 |
| GO:0043627 | Response to estrogen | 2/86 | 75/18866 | 0.045998211 | 0.215208675 | 0.174462702 | GATA3/SMAD6 | 2 |
| GO:1901983 | Regulation of protein acetylation | 2/86 | 75/18866 | 0.045998211 | 0.215208675 | 0.174462702 | GATA3/SOX4 | 2 |
| GO:0033555 | Multicellular organismal response to stress | 2/86 | 76/18866 | 0.047104673 | 0.215208675 | 0.174462702 | FBXL20/BDNF | 2 |
| GO:0071229 | Cellular response to acid chemical | 2/86 | 76/18866 | 0.047104673 | 0.215208675 | 0.174462702 | CPEB3/ATP7A | 2 |
| GO:0030324 | Lung development | 3/86 | 177/18866 | 0.047198109 | 0.215208675 | 0.174462702 | SLC7A11/ATP7A/BMPR2 | 3 |
| GO:0048771 | Tissue remodeling | 3/86 | 178/18866 | 0.047854205 | 0.215208675 | 0.174462702 | ATP7A/BMPR2/ITGB3 | 3 |
| GO:0007422 | Peripheral nervous system development | 2/86 | 77/18866 | 0.048220875 | 0.215208675 | 0.174462702 | ETV1/BDNF | 2 |
| GO:0048332 | Mesoderm morphogenesis | 2/86 | 77/18866 | 0.048220875 | 0.215208675 | 0.174462702 | BMPR2/ITGB3 | 2 |
| GO:0034329 | Cell junction assembly | 5/86 | 434/18866 | 0.048245354 | 0.215208675 | 0.174462702 | PPP1R9A/GABRB3/BDNF/ANK2/SLITRK6 | 5 |
| GO:0031098 | Stress-activated protein kinase signaling cascade | 4/86 | 300/18866 | 0.048308144 | 0.215208675 | 0.174462702 | SASH1/TGFB2/SEMA3A/PLCB1 | 4 |
| GO:0051258 | Protein polymerization | 4/86 | 300/18866 | 0.048308144 | 0.215208675 | 0.174462702 | PPP1R9A/ARHGAP28/JMY/MAP2 | 4 |
| GO:0002182 | Cytoplasmic translational elongation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | CPEB3 | 1 |
| GO:0002328 | Pro-B cell differentiation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SOX4 | 1 |
| GO:0006751 | Glutathione catabolic process | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | CHAC1 | 1 |
| GO:0006857 | Oligopeptide transport | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SLC7A11 | 1 |
| GO:0009950 | Dorsal/ventral axis specification | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SMAD6 | 1 |
| GO:0021561 | Facial nerve development | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SEMA3A | 1 |
| GO:0021604 | Cranial nerve structural organization | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SEMA3A | 1 |
| GO:0021610 | Facial nerve morphogenesis | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SEMA3A | 1 |
| GO:0031442 | Positive regulation of mRNA 3′-end processing | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | CPEB3 | 1 |
| GO:0032253 | Dense core granule localization | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | MAP2 | 1 |
| GO:0032276 | Regulation of gonadotropin secretion | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | INHBB | 1 |
| GO:0032754 | Positive regulation of interleukin-5 production | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:0034776 | Response to histamine | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | GABRB3 | 1 |
| GO:0035457 | Cellular response to interferon-alpha | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:0043455 | Regulation of secondary metabolic process | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SLC7A11 | 1 |
| GO:0043589 | Skin morphogenesis | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | TP63 | 1 |
| GO:0044848 | Biological phase | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | TGFB2 | 1 |
| GO:0046643 | Regulation of gamma-delta T cell activation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SOX4 | 1 |
| GO:0048021 | Regulation of melanin biosynthetic process | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SLC7A11 | 1 |
| GO:0048102 | Autophagic cell death | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | TP53INP1 | 1 |
| GO:0048103 | Somatic stem cell division | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | TGFB2 | 1 |
| GO:0048672 | Positive regulation of collateral sprouting | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | BDNF | 1 |
| GO:0048742 | Regulation of skeletal muscle fiber development | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | HDAC9 | 1 |
| GO:0051610 | Serotonin uptake | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | ITGB3 | 1 |
| GO:0060174 | Limb bud formation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SOX4 | 1 |
| GO:0060525 | Prostate glandular acinus development | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | TP63 | 1 |
| GO:0061085 | Regulation of histone H3-K27 methylation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:0061299 | Retina vasculature morphogenesis in camera-type eye | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | CLIC4 | 1 |
| GO:0070254 | Mucus secretion | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SYTL2 | 1 |
| GO:0070933 | Histone H4 deacetylation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | HDAC9 | 1 |
| GO:0071281 | Cellular response to iron ion | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0090084 | Negative regulation of inclusion body assembly | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SORL1 | 1 |
| GO:0090309 | Positive regulation of DNA methylation-dependent heterochromatin assembly | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | ATF7IP | 1 |
| GO:0099519 | Dense core granule cytoskeletal transport | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | MAP2 | 1 |
| GO:1900247 | Regulation of cytoplasmic translational elongation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | CPEB3 | 1 |
| GO:1900376 | Regulation of secondary metabolite biosynthetic process | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SLC7A11 | 1 |
| GO:1901950 | Dense core granule transport | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | MAP2 | 1 |
| GO:1902513 | Regulation of organelle transport along microtubule | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | MAP2 | 1 |
| GO:1904321 | Response to forskolin | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | AHR | 1 |
| GO:1904322 | Cellular response to forskolin | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | AHR | 1 |
| GO:1905245 | Regulation of aspartic-type peptidase activity | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SORL1 | 1 |
| GO:2000551 | Regulation of T-helper 2 cell cytokine production | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:2000574 | Regulation of microtubule motor activity | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | MAP2 | 1 |
| GO:2000615 | Regulation of histone H3-K9 acetylation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 2/86 | 78/18866 | 0.049346708 | 0.215208675 | 0.174462702 | GATA3/ATP7A | 2 |
| GO:0043900 | Regulation of multi-organism process | 2/86 | 78/18866 | 0.049346708 | 0.215208675 | 0.174462702 | INHBB/PLCB1 | 2 |
| GO:0060998 | Regulation of dendritic spine development | 2/86 | 78/18866 | 0.049346708 | 0.215208675 | 0.174462702 | CPEB3/PPP1R9A | 2 |
| GO:0072332 | Intrinsic apoptotic signaling pathway by p53 class mediator | 2/86 | 78/18866 | 0.049346708 | 0.215208675 | 0.174462702 | JMY/TP63 | 2 |
| GO:1903522 | Regulation of blood circulation | 4/86 | 303/18866 | 0.049775935 | 0.215208675 | 0.174462702 | TGFB2/SEMA3A/ANK2/BMPR2 | 4 |
| GO:0030323 | Respiratory tube development | 3/86 | 181/18866 | 0.049849498 | 0.215208675 | 0.174462702 | SLC7A11/ATP7A/BMPR2 | 3 |